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The toxic side effects associated with the administration of nucleoside analogs 
used to treat HIV are correlated with the kinetics of incorporation by the human 
mitochondrial polymerase γ (Pol γ).  The reconstitution of recombinant human enzyme 
has allowed for a detailed mechanistic analysis of the reactions governing nucleotide 
selectivity of the polymerase and the proofreading exonuclease.  One nucleoside analog 
in particular, zidovudine (AZT), exhibits unique kinetics of incorporation by Pol γ.  
Evidence is presented supporting a model in which the kinetics of incorporation of AZT 
differ from that of natural nucleotides and other nucleoside analogs, in that phosphoryl 
transfer is reversibly linked to binding by way of a slower than normal enzyme 
isomerization following phosphoryl transfer.  The implication of the unique reaction 
kinetics on the toxicity associated with the use of AZT is also discussed. 
The most toxic nucleoside analog approved for treatment of HIV is zalcitabine 
(ddC).  It was shown previously that the incorporation of ddC by Pol γ is relatively 
efficient and that the removal by the proofreading exonuclease was too slow to measure 
 
v 
under the conditions used.  Both efficient incorporation and slow removal are likely to 
contribute to the observed clinical toxicity.  I revisited this phenomenon by measuring the 
rate of excision more accurately and under various conditions in order to better 
understand the mechanistic basis for the slow removal of ddC. 
In addition to a role in the toxicity of nucleoside analogs used to treat HIV, Pol γ 
may play an important part in the process of aging.  The mitochondrial theory of aging 
states that electrons derived from the electron transport chain during normal respiration 
produce especially high levels of reactive oxygen species (ROS) in the mitochondria.  
These ROS can damage the mitochondrial genome, compromising its integrity.  One of 
the most common products of oxidative damage to DNA is 8-oxodG.  I have examined 
the kinetic parameters governing the replication of oxidatively damaged DNA by Pol γ 
and show that replication fidelity is reduced when incorporation is performed when 
8-oxodG is the templating base.  I provide evidence suggesting that oxidized free 
nucleotide (8-oxodGTP) may also be mutagenic. 
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Chapter 1: Introduction 
HUMAN MITOCHONDRIAL DNA POLYMERASE γ 
The mitochondrial genome is approximately 16 kilobases in length and encodes 
genes for 13 proteins involved in oxidative phosphorylation, 22 tRNAs, and 2 rRNAs 
(1;2).  The number of mitochondria per human cell varies from 100 to 1500 depending on 
tissue type and cell cycle phase (3).  With two to ten copies of the mitochondrial genome 
per mitochondria, a single somatic cell can have thousands of copies (4).  The 
mitochondrial DNA polymerase γ (Pol γ) is responsible for the replication of the 
mitochondrial genome.  Initially, our interest in Pol γ stemmed from compounding 
evidence that many of the various toxic side effects associated with the administration of 
nucleoside analogs used for the treatment of Human Immunodeficiency Virus (HIV) are a 
result of mitochondrial DNA (mtDNA) depletion.  Each of the U.S. Food and Drug 
Administration (FDA) approved nucleoside analogs terminate replication of the HIV 
genome by acting as substrates for HIV reverse transcriptase (RT).  It soon followed that 
a similar mechanism of inhibition may be occurring during replication of the 
mitochondrial genome by inhibiting Pol γ. 
Pol γ possesses 5′-3′ DNA dependent DNA polymerase activity and 3′-5′ 
exonuclease proofreading activity.  The holoenzyme is thought to be a heterotrimer 
comprised of a catalytic subunit of approximately 140 kDa and two subunits of an 
accessory protein of about 54 kDa each (5).  Both the catalytic and accessory subunits are 
nuclearly encoded and imported into the mitochondria (6).  The catalytic subunit is 
encoded by the nuclear POLG gene mapped to human chromosome location 15q24 (7).  
Pol γ is a member of the family A DNA polymerases, along with T7 DNA polymerase 
and E. coli DNA polymerase I.  Although currently the structure of Pol γ catalytic subunit 
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is unknown, it is presumed to follow the pattern of a right hand characteristic of family A 
DNA polymerases (8;9).  The accessory subunit structure has been solved and forms a 
dimer with a structure related to glycyl-tRNA synthetase, but has no catalytic activity 
(5;10).  Pol γ is in low abundance in human tissues (6), therefore, we and others have 
overexpressed the recombinant human Pol γ catalytic and accessory subunits to allow 
reconstitution of the holoenzyme (11-14).  Work in our laboratory has revealed the role 
of the accessory subunit to be a nontraditional processivity factor, in that it does not 
increase the affinity of the polymerase for DNA as thioredoxin does for T7 DNA 
polymerase (15).  The accessory subunit of Pol γ functions to increase processivity by 
increasing the rate of polymerization, but has little effect on the rate of dissociation of the 
polymerase from DNA (12).  Throughout this dissertation the term Pol γ will be used to 
refer to the reconstituted holoenzyme formed with an excess of the accessory subunit. 
Transient-state kinetic methods were used to characterize the replication of DNA 
by Pol γ.  Kinetic studies on Pol γ, and every other DNA polymerase examined with 
natural deoxynucleoside triphosphate substrates (dNTP) have shown that the pre-steady-
state burst of polymerization defines the rate of incorporation, and is followed by steady-
state dissociation of DNA from the enzyme (12;16-22). By restricting our attention to the 
first turnover and examining reactions on a millisecond time scale, we circumvent the 
slower step (DNA dissociation), limiting steady-state measurements on these processive 
enzymes.  Furthermore, kinetic parameters such as kcat and Km can be determined 
accurately with transient-state kinetic methods.  Time dependent correct dNTP 
incorporation under single-turnover conditions (enzyme in excess of DNA) by Pol γ 
follows a single exponential rate to completion (kinetic mechanism shown below). 
 
 
The rate of incorporation is dependent upon the concentration of nucleotide used, 
according to a hyperbolic relationship, which is indicative of a two-step process.  The 
first step is a fast and reversible (Kd) collision of dNTP with E/DNA complex, allowing 
for a rapid equilibrium to be established, which is followed by an isomerization (k2) of 
the enzyme, which results in both tighter binding and the proper alignment of the active 
site residues for catalysis(20;23).  The observation of a saturable rate affords the 
measurement of the maximum rate of polymerization (kpol) and the ground-state 
dissociation constant (Kd), which are equal to kcat and Km, because dNTP binding is a 
rapid equilibrium and is followed by a single rate-limiting step.  Whether the 
conformational change or chemistry (phosphoryl transfer) defines kpol for correct 
nucleotide incorporation by Pol γ has not been established, but for T7 DNA polymerase, 
mammalian DNA polymerase δ, and HIV RT evidence suggests that the conformational 
change prior to phosphoryl transfer is rate-limiting (18;24-26).   
We have previously examined the kinetic parameters governing DNA replication 
by Pol γ (11;12;19;27).  Figure 1.1 summarizes the results in a scheme redrawn from ref 
(27).  Pol γ is able to copy the DNA at an average rate of 37 s-1, with a processivity of 
1,850 bases.  The rate of excision of correctly paired DNA by Pol γ is 0.05 s-1.  Thus, the 
cost of proofreading is 0.05/(0.05+37) equal to 0.14%.  This value is comparable to that 




mismatch varied from 0.01-1.2 s-1, with the fastest rate recorded for the classic Watson-
Crick wobble base pair G:T.  The rate of excision of a single terminal mismatch increases 
to 0.4 s-1 compared to a correct terminal base pair, but the slow rate of polymerization 
over the mismatch (0.5 s-1) or stalling is the key factor in increasing the probability of 
excision.  Furthermore, stalling of polymerization continues beyond a mismatch (kpol = 2 
s-1) and the rate of excision increases further to 3 s-1, allowing proofreading to occur even 
when a mismatch is buried. 
The rate-limiting step in the excision of a single terminal mismatch is the melting 
of the primer strand from the template strand.  This was evidenced by an experiment 
showing that as the number of terminal mismatches was increased the rate of excision 
increased to a maximum rate of about 9 s-1 (7 terminal mismatches).  Excision of a 
mismatch has been shown to occur largely (80%) through an intramolecular reaction, 
meaning that the primer strand is transferred to the exonuclease site, the terminal base is 
excised, and the strand is transferred back to the polymerase site before dissociation of 
the enzyme/DNA complex.  An estimate of the overall error frequency, including the 
contribution of the 3′-5′ proofreading activity, is 1 error in 1 to 20 million bases copied 
(27).  This error frequency is considerably higher than the error frequency reported for 
nuclear DNA replication (1 error in 109 to 1010 bases copied) and could account for the 5-
100 fold higher rate of mutation in mitochondrial DNA relative to nuclear DNA (29;30).  
Accumulation of errors in the mitochondrial genome is thought to be related to aging.  A 
recent study showed that mice expressing a proofreading-deficient version of Pol γ, 
prematurely developed numerous signs of aging, apparently as a result of a reduction in 
the fidelity of replication of the mitochondrial genome (31). 
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Figure 1.1:  Kinetic parameters of polymerization by Pol γ. 
The starting DNA used in this scheme was 25/45mer DNA, and the species of DNA at 





TOXICITY OF NUCLEOSIDE ANALOGS 
Current treatments for HIV include a cocktail of nucleoside analogs, 
nonnucleoside inhibitors with fusion, and protease inhibitors.  Nucleoside analogs 
continue to be essential components of highly active antiretroviral therapy (HAART) 
combination regimens.  The major limiting aspects of current treatments are the ability of 
HIV to develop resistance to the drugs and the toxicity of the nucleoside analogs (32).  
As a class, administration of nucleoside analogs, used as anti-HIV agents, cause duration-
dependent mitochondrial dysfunction, which may be a result of three interrelated 
mechanisms: mtDNA depletion, oxidative stress, and mtDNA mutations.  It has been 
proposed that these mechanisms work in a sequential manner beginning with energy 
decline resulting from mtDNA depletion leading to related events of oxidative stress 
which can cause damage to mtDNA, ultimately leading to mutations in the mitochondrial 
genome (33). 
Effectiveness and toxicity of any given nucleoside analog are likely results of 
many factors including uptake, transport, metabolic activation, incorporation, and 
degradation (34-40).  As a result of these many factors that influence bioavailability, 
toxicity is cell-, tissue-, and organ-specific.  Patients treated with one or more nucleoside 
analogs may experience a variety of side effects including peripheral neuropathy, 
myopathy, pancreatitis, and bone marrow suppression (41).  There are currently a total of 
eight FDA approved nucleoside analogs, given in order of approval:  3′-azido-2′,3′-
dideoxythymidine (AZT); 2′,3′-dideoxyinosine (ddI); 2′,3′-dideoxycytidine (ddC); 2′, 3′-
didehydro-2′,3′-dideoxythymidine (d4T); β-L-(-)-2′,3′-dideoxy-3′-thiacytadine (-3TC); (-
)-cis-2-amino-1,9-dihydro-9-(4-hydroxymethyl)-(2-cyclopenten-1-yl)-6H-purine-6-1 
(CBV); (R)-9-(2-phophonyl-methoxypropyl)adenine (PMPA); and 5-fluoro-1-(2R,5S)-
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[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (FTC).  The structures of these analogs 
are given in Figure 1.2, along with 1-(2′-deoxy-2′-fluoro-beta-D-arabinofuranosyl)-5-
iodouridine (FIAU).  PMPA, a nucleotide analog, is administered orally as the prodrug 
tenofovir disoproxil.  This improves the lipophilicity of PMPA and increases diffusion 
across the plasma membrane (42).  The structure of PMPA is shown without the 
hydrolysable lipophilic groups in Figure 1.2.  In a similar view, 3% of ddI is 
intracellularly converted into its active form ddATP, (43;44), and CBV is given as the 
prodrug abacavir. 
Each of the nucleoside analogs are administered orally in an inactive form and 
require subsequent phosphorylation by host cell kinases to the triphosphate, which can 
then act as substrates for RT (45).  Nucleoside analogs are designed to target RT.  They 
are incorporated into the viral genome during replication and cannot be removed because 
RT lacks a proofreading exonuclease function.  Therefore, the specificity of nucleoside 
analogs towards RT results from discrimination between correct nucleotides and/or 
excision by proofreading of the host cellular DNA polymerase (32).  As mentioned 
earlier, the nucleoside analogs approved by the FDA to date lack a 3′-OH group 
necessary to continue elongation, and thus they act as chain terminators to effectively 
inhibit viral replication, allowing patients to coexist with a low viral load for years when 
used in combination with nonnucleoside RT and protease inhibitors.  Although such 
treatment extends patients’ lives significantly, the toxicity that results is still limiting. 
Side effects resulting from the toxicity of this class of drugs are, by and large, 
reminiscent of heritable mitochondrial diseases.  In addition, in vivo studies with AZTTP 
have been shown to cause ultrastructural changes in mitochondria (46;47).  In contrast to 
other nucleoside analogs AZT causes bone marrow toxicity, which is thought to be due to 
inhibition of one or more of the chromosomal DNA polymerases (48).  In 
 
nonproliferating cells nucleoside analogs, including AZT, have been documented to 
inhibit Pol γ specifically (48-52).  Many of the nucleoside analogs designed for the 
treatment of HIV, hepatitis B virus (HBV), and other viruses are structurally similar. 
 
 
Figure 1.2: Structures and FDA approval dates of nucleoside analogs 
The structures of eight approved nucleoside analogs in addition to FIAU are shown.  
FIAU is not a chain terminator. In an initial clinical trial with HBV infected patients 





The initial clinical trial with FIAU on chronic HBV infected patients resulted in 
the death of five patients (54).  The toxicity that arose from FIAU was manifest clinically 
by the presence of myopathy, lactic acidosis, pancreatitis, and hepatic steatosis (55).  
Based on the evident mitochondrial toxicity, a comparative in vitro study using 
mammalian DNA polymerases α, β, γ, δ, and ε purified from various tissues revealed that 
while FIAU was incorporated into the nascent DNA chain by all the polymerases, Pol γ 
was the most efficient (56).  One significant difference between FIAU and other 
nucleoside analogs is the presence of a 3’-OH creating an opportunity for FIAU to be 
stably incorporated into the mitochondrial genome in vivo (57), and may explain the 
extreme toxicity seen.  Studies in our laboratory revealed a kpol of 24 s-1 for FIAUTP (TP 
designates triphosphate), identical to dTTP (58), and a Kd only five-fold weaker.  
Therefore, the ratio of specificity constants (discrimination) 
((kpol/Kd)correct/(kpol/Kd)incorrect) predicts that one in five template dAMPs, FIAU will be 
incorporated (assuming the concentration of competing substrates are equal, which is not 
a valid assumption for in vivo conditions).  Furthermore, it was shown that there is a 68% 
probability that FIAU will be buried after incorporation rather than excised by the 
proofreading exonuclease.  Once internalized into the mtDNA, FIAUMP may likely 
serve as a potent mutagen by altering dNTP selectivity or DNA topology (59). 
Based on our kinetic studies examining the ability of Pol γ to discriminate against 
nucleoside analogs and also efficiency of proofreading, we defined a toxicity index to 
take into account the relative concentration of the analog triphosphate (AnaTP) compared 
to the natural dNTP, the rate of incorporation, and the rate of exonuclease removal (60).  
The toxicity index provides a method to rate compounds for their potential toxicity, and is 
defined as: 
toxicity index = (kpol/kexo)([AnaTP]/[dNTP])/4D 
 
10 
where, kpol is the maximum rate of incorporation, kexo is the rate of exonuclease removal, 
and D is discrimination.  By this definition, the toxicity index gives the fractional 
increase in time required to replicate the mitochondrial genome.  The toxicity index for 
nucleoside analogs examined in our laboratory is shown on a log scale as a bar graph in 
Figure 1.3 (adapted from ref (60)).  The index was created assuming that the 
concentration of AnaTP and dNTP are equal, which is not generally the case, but is 
useful for illustrative purposes.  The predicted toxicities vary over 6 orders of magnitude 
and generally follow the observed clinical side-effects.  For example, dose-dependent 
peripheral neuropathy is the major treatment-limiting adverse effect of nucleoside 
analogs and is commonly seen following treatment with ddC, d4T and ddI, but not 
consistently with AZT, 3TC or CBV (26).  It must be noted that this analysis does not 
account for the fact that cells replicating at higher rates may be more sensitive, and also 
that the bioavailability of each analog depends on many factors.  In addition, the high 
copy number of the mitochondrial genome and any possible effect on gene expression 
resulting from chain termination are ignored.  However, the toxicity index given here 
correlates well for clinically observed toxicities and should be useful to predict the 
toxicity of new compounds (32). 
 
 
Figure 1.3:  Toxicity index of nucleoside analogs 
The toxicity index values calculated as described in the text are plotted on a log scale 
spanning 6 orders of magnitude.  The index represents the fractional increase in time it 
takes to replicate the mitochondrial genome in the presence of an equal concentration of 
dNTP and nucleotide analog (in the triphosphate form).  The concentrations of dNTP and 
nucleoside analog were assumed to be equal for comparative purposes only, and do not 
reflect physiological values.  All drugs plotted except (+)3TC, and ddA (active form of 





Of particular interest was the observation of qualitatively different incorporation 
of AZTTP by Pol γ.  As stated earlier the rate of incorporation of correct nucleotides by 
Pol γ is dependent upon the concentration of nucleotide present in the experiment.  This 
was also the case for all the nucleoside analogs, except AZTTP.  Unlike other nucleotides 
the rate of AZTTP incorporation was relatively constant as concentration increased, but 
the amplitude was dependent according to a hyperbolic relationship.  It was proposed that 
the underlying distinction for AZTTP incorporation was that binding could be reversibly 
linked to phosphoryl transfer (32), but this proposal remains to be tested.  Another 
interesting nucleoside analog, ddC, exhibited a distinctive feature that could explain the 
severe toxicity seen clinically.  The rate of excision of ddC was extremely slow compared 
to the other nucleoside analogs.  This, in essence, reduces the comparison of effectiveness 
and toxicity to the abilities of RT and Pol γ to discriminate against ddCTP during 
incorporation, since neither polymerase has the ability to repair the termination.  Further 
studies on the kinetics of the incorporation of AZT and the removal of ddC are part of 
this dissertation. 
A detailed understanding of the mechanism by which antiviral drugs act to slow 
or inhibit mitochondrial replication is paramount in defining molecular attributes that 
cause and alleviate toxicity.  More studies need to be undertaken in order to identify the 
exact structural features that take advantage of the differences in selectivity between Pol γ 
and HIV RT. 
MITOCHONDRIAL THEORY OF AGING 
According to the mitochondrial theory of aging, electrons from the electron 
transport chain, most likely from complex I are able to reduce O2 to form superoxide 
anion radicals (O2-) during aerobic respiration.  These reactive radicals go on to produce 
other reactive oxygen species (ROS) (61).  ROS can be generated at a few cellular sites, 
 
but in healthy tissues, the majority are a result of metabolism.  ROS attack a variety of 
cellular macromolecules, including proteins, lipids and DNA.  However, damage to 
mtDNA has been implicated as the most important in regard to aging, especially in 
postmitotic cells such as neurons (62-70). 
One of the most common and significant products of oxidative DNA damage is 8-
hydroxy-2′-deoxyguanosine (8-oxodG), which is mutagenic and is commonly used as 
biomarker for oxidative stress.  Basal levels of 8-oxodG in mtDNA comparing different 
species correlate negatively with longevity in many mammals and birds, which is not the 
case with nuclear DNA (nDNA) (71).  Moreover, as a result of the proximity of mtDNA 
to the electron transport chain, the levels of oxidative damage are significantly higher in 
all tissues of mammals and birds than in the nucleus (72). 
The concern surrounding 8-oxodG stems from its mutagenic coding potential 
when copied by an assortment of mammalian and prokaryotic polymerases (73-75).  For 
all studies done with DNA polymerases, dC and dA were inserted across from 8-oxodG 
with comparable efficiencies which potentially results in a G to T transversion mutation 
if gone unrepaired.  The molecular mechanism for the lack of specificity afforded by 8-
oxodG is thought to be due to the ability to form either a normal Watson-Crick hydrogen 
bonding arrangement with dCMP or a Hoogsteen base pair with dAMP by flipping to the 





However, there are currently no detailed biochemical studies with the human 
mitochondrial polymerase γ examining the mutagenic potential of this oxidative lesion.  
Therefore, one chapter of this dissertation is devoted to the kinetic characterization of 
oxidatively damaged DNA replication by Pol γ  
PROJECT SUMMARY 
The projects reported in this dissertation can be divided into four main categories.  
Overexpression and purification of Pol γ holoenzyme using bacteria was carried out as an 
attempt to obtain a higher quality protein preparation (Chapter 2).  A protocol was 
developed to separate and quantify products of single nucleotide incorporation reactions 
with a fluorescently labeled DNA substrate by capillary electrophoresis (Chapter 3).  A 
detailed kinetic analysis of AZT incorporation by Pol γ was performed to explain the 
confusion regarding anomalous results obtained previously in our laboratory (Chapter 4).  
In line with this study was a brief examination of ddC excision in order to clarify the 
basis for inefficient removal (Chapter 5).  The kinetic parameters governing the 
replication of oxidatively damaged DNA were obtained in order to contribute a much 
needed detailed study for the field of aging and age related diseases (Chapter 6). 
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Chapter 2: Expression and Purification of Pol γ Holoenzyme in Bacteria 
INTRODUCTION 
Previous attempts at the overexpression of recombinant Pol γ catalytic subunit in 
bacteria yielded poor results.  A large quantity of protein was expressed, but it was 
wholly insoluble, which forced the use of a eukaryotic expression system employing a 
baculovirus vector and SF9 cells (11).  Overexpression of the accessory subunit for Pol γ 
in bacteria was achieved, and the holoenzyme reconstituted with the two subunits (12).  
Bacterial expression systems have considerable advantages over the eukaryotic system 
we are currently using, namely, ease of site-directed mutagenesis, potentially better yield, 
lower cost, and less maintenance.  The following research was an attempt to improve the 
expression of the catalytic subunit in bacteria by co-expressing the accessory subunit 
using a vector with two promoters and two cloning regions.  It was hypothesized that the 
presence of the accessory protein could stabilize or aid in the folding process of the 
catalytic subunit during late stage synthesis.  Additionally, degradation of the catalytic 
subunit was apparent in preparations from SF9 cells, and it is reasonable that the presence 
of the accessory subunit during expression and purification may reduce proteolysis.    
MATERIALS AND METHODS 
Bacterial overexpression of Pol γ holoenzyme 
The large and small subunits were both inserted into the pETDuet-1 vector EMD 
Biosciences, Inc. (Madison, WI), designed for the co-expression of two target genes. The 
vector encodes two multiple cloning sites (MCS) each of which is preceded by a T7 
promoter/lac operator and ribosome binding site (rbs). The vector also carries the 
pBR322-derived ColE1 replicon, lacI gene and ampicillin resistance gene.  The small 
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subunit cDNA was inserted first because of restriction site limitations.  PCR was used to 
create an insert with an Nco I site and a Methionine codon immediately prior to the 58th 
amino acid from the amino terminus along with a Afl II site on the carboxyl terminus of 
the cDNA.  A six histidine tag was cloned in during PCR with a stop codon directly 
following the tag.  The insert was then introduced into pETDuet-1 vector.  The procedure 
was repeated for the large subunit insert, but with restriction digest sites of Mun I (N-
terminus) and EcoR V (C-terminus).  An N-terminal 68 amino acid truncation was cloned 
based on sequence analysis, based upon an estimate of the putative mitochondrial import 
signal sequence.  This insert also contained a six histidine tag introduced during PCR 
followed by a stop codon.  A vector map summarizing the cut sites and placement of 
cDNA is shown in Figure 2.1.  The expression construct was transformed into 
BL21(DE3) cells. The transformed BL21(DE3) cells were grown to an OD600 of 0.4 in 
TB media including ampicillin at 100 µg/mL, at which time the temperature was reduced 
to 12oC in either a 5 L Biostat fermenter, Sartorius AG (Goettingen, Germany) or a 16 L 
glass carboy equipped with an aerator (the carboy was placed in a refrigerated incubator 
to control the temperature for overexpression).  Protein production was induced by the 
addition of isopropyl-D-thiogalactopyranoside to 0.5 mM.  After 24 h of induction at 
12oC, the cells were harvested by centrifugation for 20 minutes at 3000 rpm in a 
Beckman JL-8 rotor at 4oC. Cell pellets were then frozen in liquid nitrogen.  The growth 
conditions in the fermenter were 600 rotations per minute, 1.5 L/min air (vacuum pump 




Figure 2.1:  pETDuet-1 vector map 
The cDNA for the accessory subunit (shown on the right hand side) was inserted into the 
vector prior to the catalytic subunit cDNA because the cut sites used were present in the 
cDNA for the catalytic subunit.  A C-terminal 6X histidine tag just prior to a stop codon 
was cloned in during PCR for both the accessory subunit and the catalytic subunit.  The 
cut sites used for cloning are shown on the right hand side with placement of the histidine 
tags.  The map shown was modified from the pETDuet-1 vector map in the product 







All SDS-polyacrylamide gels were performed according to the method of 
Laemmli (78). A separating gel of 10% was used for all gels, and proteins were 
visualized with Coomassie blue R-250 (79).  
Purification 
All procedures were carried out at 4oC unless otherwise specified.  The bacterial 
cell pellets were thawed and resuspended in 5 volumes (mass to volume) of lysis buffer 
(20 mM Tris-Cl pH 8.0 @ 4oC, 500 mM NaCl, 0.1% Triton X-100, 60 µg/mL lysozyme, 
0.2 mM phenylmethylsulfonyl fluoride, and 0.7 µg/mL leupeptin). The suspension was 
stirred at 4oC for 1 hour to lyse the cells. The lysate was sonicated on ice until it lost 
viscosity and then centrifuged for 40 min at 16,000 rpm in a Beckman JLA 16.250 rotor 
at 4oC. 
Chelating Sepharose Chromatography 
Chelating Sepharose Fast Flow (Amersham Biosciences, Uppsala, Sweden) was 
prepared by washing 10 mL of resin with five volumes of distilled water, five volumes of 
400 mM NiSO4, and three volumes of binding buffer (20 mM Tris-HCl, pH 8.0, 500 mM 
NaCl, and 5 mM imidazole).  As a result of the volume of lysis buffer used to resuspend 
the large mass of cell pellet (approximately 450 grams) the supernatant of the bacterial 
lysate was stirred with pre-equilibrated resin for 30 min instead of employing a 
traditional column.  The mixture was centrifuged for 10 min in a Beckman JLA 16.250 
rotor at 500 rpm to collect the resin.  The resin was resuspended with 25 mL of binding 
buffer, and poured into a 50 mL column, which was then transferred to the FPLC.  A 
flow rate of 2 mL/min was used for the nickel column.  A gradient of 5-400 mM 
 
19 
imidazole was used to elute the protein.  Fractions containing holoenzyme, as analyzed 
by SDS-PAGE and Western blot, were collected and dialyzed into buffer containing 50 
mM Tris-HCl, pH 7.2, 50 mM NaCl, 5 mM EDTA, and 10% glycerol. 
Single-Stranded DNA Cellulose Chromatography 
A 10 mL single stranded DNA cellulose column (Sigma Aldrich) was poured and 
equilibrated with 50 mM Tris-HCl, pH 7.2, 50 mM NaCl, 1 mM DTT, 5 mM EDTA, and 
10% glycerol (TDEG) buffer at pH 7.9 containing 50 mM NaCl.  The dialysate from 
above was loaded onto this column at 1 mL/ min.  The protein was eluted with a 100 mL 
gradient from 50 mM NaCl to 1 M NaCl in TDEG buffer at pH 7.9.  Fractions containing 
holoenzyme were pooled and dialyzed against TDEG at pH 7.2 containing 50 mM NaCl 
for 4 hours in a 25,000 Dalton MWCO membrane. 
Mono-S Chromatography 
The dialysate from above was loaded at 1.0 mL/min onto a HR5/5 Mono-S 
column (Pharmacia, Uppsala, Sweden) that had been equilibrated with TDEG at pH 7.2 
containing 50 mM NaCl.  The column was washed with equilibration buffer until the A280 
returned to baseline.  The protein was eluted with a 10 mL gradient from 50 mM NaCl to 
1 M NaCl in TDEG at pH 7.2 at 0.5 mL/min.  The pooled fractions were dialyzed against 
TDEG (50% glycerol) at pH 8.4 containing 100 mM NaCl overnight.  The dialyzed 
fractions were then frozen in liquid nitrogen and stored at -80°C.  The protein 
concentration was measured by SDS gel electrophoresis Coomassie dye binding assay 
using BSA as a standard curve. 
Preparation of DNA 
A DNA primer and template of 25 and 45 nucleotides, respectively, was 
employed for the polymerase activity assay.  The primer sequence was 5′-
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GCCTCGCAGCCGTCCAACCAACTCA-3′, and the template sequence was 5′-
GGACGGCATTGGATCGAGGGTGAGTTGGTTGGACGGCTGCGAGGC-3′.  Primer 
was 5′-32P-labeled using T4 polynucleotide kinase, according to the manufacturer’s 
instructions (Life Technologies, Gaithersburg, MD). The reaction was terminated by 
incubation at 95°C for 5 minutes, and excess nucleotide was removed using a Bio-Spin 6 
column (BioRad, Hercules, CA).  Primer was annealed to 45-mer template by combining 
at an equimolar ratio, heating to 95 °C, and slowly cooling to room temperature. 
Single nucleotide incorporation assay 
A quench-flow apparatus (RFQ-3) from KinTek Corp. (Austin, TX) was used to 
rapidly mix and quench the reactions.  Incorporation assays were performed at 37oC in 
buffer containing 50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 2.5 mM MgCl2.  Incorporation 
reactions were initiated by the addition of nucleotide and magnesium in the same reaction 
buffer at 37 °C and then quenched with 0.5 M EDTA.  All concentrations given are 
concentrations after mixing.  Products were separated on 15% denaturing polyacrylamide 
sequencing gels, imaged on a Molecular Dynamics Storm 860, and quantified using 
ImageQuaNT software (Amersham Biosciences, Uppsala, Sweden).  Product formation 
as a function of time was fit to the burst equation ([product] = A1*e-k1t +ksst + C), where 
A1 is the amplitude, k1 is the burst rate, and kss is the steady-state rate. 
RESULTS 
In an attempt to obtain soluble Pol γ holoenzyme using bacteria the pET-Duet-1 
vector was employed because it was designed for the overexpression of two proteins 
simultaneously.  It was thought that the accessory subunit, which has been successfully 
overexpressed in bacteria, may be able to stabilize the catalytic subunit, rendering it 
soluble and active.  Sequencing results confirmed that cloning of the catalytic and 
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accessory subunit cDNA inserts into the pET-Duet-1 vector was successful and an 
induction trial was run (Figure 2.2) at 37oC for four hours.  The large subunit expressed at 
a high enough level to be visible in the total cell lysate, but when the lysate was cleared, 
greater than 95 percent pelleted with the cellular debris at 37oC.  Temperatures as low as 
12oC were attempted with a slightly better outcome, however such a small amount of 
protein was soluble that it could only be observed by western blot (Data not shown).   
To look for the presence of soluble active Pol γ holoenzyme the volume of cell 
culture was scaled-up for preparation and purification of the two subunits.  Large scale 
purification of the holoenzyme was performed by growing a 5 L culture in a fermenter 
and 16 L in a glass carboy.  The overexpression of the holoenzyme was similar regardless 
of whether it was performed in a fermenter or a carboy.  Expression was carried out for 
24 hours at 12oC and the pellets were combined for a total pellet mass of 450 grams.  A 
batch method was used for the chelating sepharose affinity chromatography since the two 
subunits were his-tagged and there was a large volume of cleared lysate (detailed in the 
materials and methods section).  A gradient of 5 mM to 400 mM imidazole was run 
rather than a step elution which is usually performed for this type of column to separate 
the holoenzyme from contaminants more effectively (Figure 2.3A).  A faint band at the 
correct molecular weight was apparent on the Coomassie blue stained gel, which was 
confirmed by western blot.  The remaining portion of the procedure was adapted from the 
protocol previously developed in our laboratory for the purification of the catalytic 
subunit alone which was overexpressed in a baculovirus-SF9 cell expression system (11).  
Briefly, ssDNA cellulose chromatography and Mono S cation exchange chromatography 
columns were run with success (Figure 2.3B).  The two subunits co-eluted from the 
ssDNA column, but at slightly different salt concentrations.  A control elution was run 
with holoenzyme reconstituted with catalytic subunit purified from the baculovirus 
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expression system and accessory subunit purified from bacteria with similar results (Data 
not shown).  A steep gradient was run for the mono S column to concentrate the protein 
prior to final dialysis (Figure 2.3C).  It is apparent from the gel that the preparation did 
not result in a homogenous mixture of the holoenzyme; furthermore the accessory subunit 
was in great excess of the catalytic subunit.  However, the large excess of small subunit is 
not a significant issue for our kinetic assays, as we reconstitute the holoenzyme by adding 
a five molar excess of small subunit to the catalytic subunit.  The approximate yield from 
21 L (450 g cell pellet) of culture was 50 µg of catalytic subunit. 
A rapid mixing experiment was performed with the holoenzyme under burst 
conditions (DNA in excess of enzyme) with the holoenzyme to examine its activity.  A 
final concentration of only 12 nM could be achieved because the stock holoenzyme 
concentration was low.  Therefore, 12 nM holoenzyme was preincubated with 300 nM 
DNA and mixed with Mg+2 and 100 µM dCTP (a single dC was to be inserted according 
to the template sequence) to start the reaction.  The reaction was quenched with 0.5 M 
EDTA at specified time points (Figure 2.4).  The amplitude of the burst was 6.4 ± 0.8 nM 
and the burst rate was 35 ± 7 s-1.  The amplitude of the incorporation reaction 
corresponds to the concentration of productively bound enzyme/DNA complex in 
solution; therefore, it was about 50 percent active and had a normal burst rate for dCTP 
incorporation.  However, the steady-state rate was much faster (7.4 ± 1.1 s-1) than 
previously observed (0.02 s-1), which has been shown to be the rate of dissociation of the 
enzyme/DNA complex.  The reason for the fast steady-state rate is unknown, but the rate 
measured previously with holoenzyme reconstituted from the catalytic subunit prepared 
from the baculovirus expression system was a construct that expressed 39 more amino 





































Figure 2.2:  Bacterial expression of Pol γ induction trial 
Shown is an induction trial for the co-expression of the catalytic and accessory subunits 
carried out at 37oC for 4 hours.  The positive control has both the large and the small 
subunits, along with degradation products of the large subunit (middle band).    The large 
subunit is obvious in the total cell lysate, and is slightly smaller than the control due to a 









































































































Figure 2.3:  SDS-PAGE analysis of Pol γ purification 
(A) SDS-PAGE analysis of cell lysis and chelating sepharose affinity chromatography.  
The large subunit of Pol γ is marked with an arrow, showing that most of the protein after 
clearing the lysate was in the pellet indicating that it was largely insoluble (upper left-
hand gel).  There is a small amount of soluble protein in the elution of the nickel column 
which was pooled and dialyzed for the next column (upper right-hand gel).  (B) ssDNA 
affinity chromatography was effective at purifying the large and small subunits (lower 
left-hand gel).  The small subunit is the most intense band in the elution.  (C) Mono S 




















Figure 2.4:  Single-nucleotide incorporation by Pol γ holoenzyme 
Pol γ holoenzyme (12 nM) was preincubated with 300 nM DNA and rapidly mixed with 
dCTP and Mg+2 to start the reaction.  At times plotted on the graph the reaction was 
quenched with 0.5 M EDTA.  Product formation as a function of time was plotted and fit 
to a burst equation to obtain a burst amplitude of 6.4 ± 0.8 nM, a burst rate of 35 ± 7 s-1, 
and a steady-state rate of 7.4 ± 1.1 s-1, revealing that about 50 percent of the enzyme was 
active with a normal burst rate.  A steady-state rate of 7.4 s-1 is 370-fold faster than we 





It was shown that it is possible to obtain soluble active Pol γ holoenzyme by co-
expressing the two subunits simultaneously in bacteria, whereas expression of the 
catalytic subunit alone results in no soluble protein.  However, a yield of 50 µg per 21 L 
of cell culture is not sufficient to make the purification favorable over our previously 
established protocol.  The percentage active sites was comparable to that obtained using 
the eukaryotic expression system as was the burst rate.  However the steady-state rate of 
the single nucleotide incorporation reaction was 370-fold faster, which for most enzymes 
might indicate that the preparation was higher in quality, but in this case the fast turnover 
rate suggests that this particular truncation may have reduced the affinity for DNA.  The 
same truncation used for our current studies (29 amino acids) was attempted using the 
pET Duet vector and identical purification conditions but the catalytic subunit was 
completely insoluble for unknown reasons. 
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Chapter 3: Analysis of Single Nucleotide Incorporation Reactions by 
Capillary Electrophoresis 
INTRODUCTION 
DNA polymerases are often processive enzymes, catalyzing the incorporation of 
thousands of bases before dissociating from the primer/template.  The following method 
was developed with recombinant human mitochondrial polymerase γ holoenzyme (Pol γ), 
which catalyzes roughly 1850 nucleotides during a single DNA binding event (19).  
Because of this processivity, it is necessary to employ transient-state kinetic methods, 
using a rapid chemical quench flow, to quantify the incorporation of a single nucleotide 
under conditions where the polymerase and DNA are at a near stoichiometric ratio.  
Under conditions where DNA is in a 3-fold excess over Pol γ, a burst of product 
formation is observed followed by a linear phase, allowing the measurement of the pre-
steady-state rate of incorporation, the absolute amount of productively bound enzyme-
DNA complex, and the slower steady-state rate of turnover limited by the rate of 
dissociation of the enzyme-DNA complex (12).  Traditionally, a small radio-labeled 
synthetic oligonucleotide primer annealed to a longer template is used for the extension 
reaction.  Substrate (DNAn) is then separated from product (DNAn+1) using denaturing 
polyacrylamide gel electrophoresis (PAGE).  In addition to the requirement of using a 
radiolabel, PAGE is labor intensive, time consuming and wasteful in terms of reagents. 
Using laser-induced fluorescence (LIF) in combination with capillary 
electrophoresis (CE) alleviates some of the problems associated with PAGE and allows 
one to streamline, and automate product analysis.  CE also allows one to eliminate the 
use of radioactive materials.  An overview of the technique used for this report is shown 
in Figure 3.1.  Moreover, a method that can detect fluorescence will allow for more 
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complex experimental designs using multiple fluorophores.  Fluorescence methods are 
not without limitations beyond sensitivity and the resolution of products.  For example, 
we have encountered problems due to non-specific interactions between the fluorophore-
labeled DNA and the enzyme that inhibit polymerization.  In addition resolution of the 
primer by CE has been hampered by the formation of heteroduplex with the template, 
present at stoichiometric concentrations.  In the following report we will discuss our 
initial failed attempts to use published methods, our solutions to the technical difficulties, 
as well as the capabilities and limitations of the method. 
 
 





Figure 3.1:  Overview of capillary electrophoresis technique 
(A)  To load the polyacrylamide gel into the capillary, 50 psi was applied to the left vial 
(gel) for 20 minutes.  A capillary length of 50 cm, to the LIF window, was used with the 
best results.  (B)  Samples were electrokinetically injected with an electric potential of 10 
kV for 60 seconds.  (C)  Separation was performed at an electric potential of 18 kV.  
Because of the relatively long capillary, more than a single sample can be loaded prior to 
the LIF window by “separating” the injected sample for only 5 minutes (simply to move 
the sample into the capillary a short distance) and then injecting a second sample as 
shown in (B) and separating again.  A total of 12 points can be injected in this fashion.  
Then a final separation of about 75 minutes can be performed to record the fluorescence 






MATERIALS AND METHODS 
Instrumentation 
The P/ACE MDQ equipped with both the 488 and 635 nM laser modules was 
used for capillary electrophoresis (Beckman Coulter, Inc.).  The eCAPTM ssDNA 100-R 
kit, also available from Beckman Coulter, Inc., was used as a guide to begin the method 
development.  Instead of using a 27 cm (20 cm to window) capillary, a 57 cm (50 cm to 
window) was needed.  Experiments done with the 27 cm capillary did not resolve DNAn 
from DNAn+1, when DNAn+1 was less than 5 % of the total DNA (Data not shown).  A 57 
cm capillary required longer separation times, but this could be countered by sequential 
loading of multiple samples, followed by their individual resolution.  Such sample 
stacking was performed by injecting multiple times with a 5 minute separation (18 kV) 
between each injection.  Up to 12 samples were electrokinetically injected for 60 seconds 
at 10 kV and, after all the samples were injected, separated at 18 kV for 70-90 minutes.  
Separation time was variable because the migration time of the primer depended on the 
primer length and the viscosity of the ssDNA 100-R gel.  The viscosity of the ssDNA 
100-R gel provided with the eCAPTM ssDNA 100-R kit varied for unknown reasons, but 
the resolution did not.  After each 12-point time course was resolved, the gel was 
replaced and equilibrated.  Gel loading and replacement times were extended 2-fold to 20 
minutes, to compensate for the use of the 57 cm capillary.  Transient-state polymerase 
reactions were performed using the RQF-3, rapid chemical quench-flow (www.kintek-
corp.com). 
Enzyme 
Purification and characterization of the Pol γ catalytic subunit were as reported 
previously (11) using an exonuclease-deficient (E200A) enzyme.  The accessory subunit 
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was purified and used to reconstitute the holoenzyme as reported previously (12).  Pol γ 
catalytic subunit was pre-incubated on ice for 20 minutes with the accessory subunit at a 
stoichiometric ratio of 1:5 to reconstitute the holoenzyme. 
DNA 
All oligonucleotides were purchased from Integrated DNA Technologies, 
Coralville, IA, and were purified using 15% denaturing PAGE.  The primer/templates 
used are shown in Figure 3.2.  The two 5′-fluorescently labeled (BodipyTM 630/650 and 
6-FAMTM) 25/45mer primer/templates were identical in sequence to the radiolabeled 
primer/template, except for a single T:A pair (G:C in the radioactive control) at the 5′-
end.  Since 5′-G is less efficiently labeled according to Integrated DNA Technologies, the 
sequence was modified.  Purity of the fluorescently labeled primers was assessed by 
capillary electrophoresis (approximately 96 %) (Figure 3.3 inset).  The concentrations of 
primer and template were obtained by measuring absorbance at 260 nm using the 
extinction coefficients provided by Integrated DNA Technologies.  Labeled primer was 
combined with 45mer template at an equimolar ratio, heated to 95 °C, and annealed by 























Figure 3.2: Sequences of oligonucleotides 
The sequences of primer/template combinations used for the experiments are shown.  The 
25/45mers were identical to the radioactive control, except for the 5′-base, where it was 




Preparation of radiolabeled DNA 
Primer was 5′-32P-labeled using T4 polynucleotide kinase, according to the 
manufacturer’s instructions (Life Technologies, Gaithersburg, MD). The reaction was 
terminated by incubation at 95°C for 5 minutes, and excess nucleotide was removed 
using a Bio-Spin 6 column (BioRad, Hercules, CA). 
Product Analysis 
Polymerase assay reactions using radiolabeled DNA were separated using 15% 
denaturing polyacrylamide sequencing gels, imaged on a Molecular Dynamics Storm 860 
and quantified using ImageQuaNT software (Amersham Biosciences, Uppsala, Sweden).  
To normalize data, the integrated amount of product (DNAn+1) was divided by the sum of 
the substrate and product (DNAn + DNAn+1) and multiplied by the concentration of DNA 
used in the experiment.  For assays using a fluorescent probe, peaks were analyzed by 
integration using the P/ACE system MDQ software, version 2.3 (Beckman Coulter, Inc.).  
To normalize data, the peak area of product (DNAn+1) was divided by the sum of the peak 
area of substrate and product (DNAn + DNAn+1) and multiplied by the concentration of 
DNA used in the experiment.  The time dependent changes in product concentration were 
fit to the burst equation ([DNAn+1] = A*e-kt + kss + C) using Grafit 5 software (Erithacus 
Software, Horley Surrey RH6 9YJ UK) where [DNAn+1] is the product concentration, A 
is the amplitude, k is the burst rate, kss is the steady-state rate, C is the offset, and, t is 
time. 
Reagents 
The eCAPTM ssDNA 100-R kit purchased from Beckman Coulter Inc. included all 
the necessary materials and reagents for performing capillary electrophoresis, except for 
the formamide used in the sample buffer, which was purchased from Sigma Aldrich Corp 
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(St. Louis, MO).  Unless otherwise stated, capillary electrophoresis materials and 
reagents were prepared according to product literature.  All other reagents and chemicals 
were purchased from Sigma Aldrich Corp. 
RESULTS 
Our goal was to rapidly resolve products from single nucleotide incorporation 
reactions either under burst or single-turnover (enzyme in excess over DNA) conditions.  
Because the pre-steady-state incorporation reaction for natural nucleotides proceeds at an 
average rate of 37 s-1 for Pol γ, it is necessary to use a rapid chemical quench-flow to mix 
and quench the reaction in the millisecond time scale.  To form the enzyme-DNA 
complex, Pol γ holoenzyme was mixed with 5′-fluorescently labeled primer annealed to a 
45mer nucleotide template, and allowed to equilibrate on ice for 20 minutes.  A solution 
of the next correct nucleotide (with Mg+2) was prepared separately.  After mixing E-DNA 
with Mg-dNTP 1:1 in the quench-flow instrument, the mixture contained 100 nM Pol γ 
holoenzyme, 300 nM DNA, 100 µM nucleotide, 50 mM tris (hydroxymethyl)-
aminomethane (Tris), 100 mM NaCl, 5mM MgCl2, and 0.1 mg/mL bovine serum 
albumin (BSA), pH 7.4 @ 37oC.  A reaction volume of 30 µL was quenched with 80 µL 
of 0.5 M ethylene-diamine-tetra-acetic acid (EDTA) and then mixed with 80 µL sample 
buffer containing 50% formamide.  Samples were then loaded into a 96-well plate and 
heated to 95oC for 5 minutes.  Figure 3.3A shows an electropherogram of the reaction 
mixture at zero time.  We expected to observe one peak corresponding to substrate 
(27mer in this case), but two were present.  Figure 3.3B shows an electropherogram after 
a 0.12 s reaction.  A portion of substrate was expected to be converted to product, which 
is seen to the left of the electropherogram, where there is a group of two peaks 
corresponding to DNAn and DNAn+1, but following those peaks were two other peaks.  It 
was clear that some of the primer was migrating as duplex.  Surprisingly, sample buffers 
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containing either 8 M urea or 100% formamide were unable to eliminate the second set of 
peaks, even though the ssDNA 100-R gel was prepared with 7 M urea and run at 30oC.  
The two peaks representing primer migrating as duplex were ultimately eliminated by the 




















































Figure 3.3: Resolution of an oligonucleotide primer, DNAn, and DNAn+1
(A) An electropherogram of a sample that was quenched with 0.5 M EDTA before 
nucleotide was added (zero time), with final reaction conditions of 300 nM DNA and 100 
nM Pol γ holoenzyme.  At zero time we expected only a single peak corresponding to 
substrate, DNAn.  (Inset) An electropherogram depicting a 27mer oligonucleotide 5′-6-
FAMTM labeled, which was purified using 15% denaturing PAGE.  This oligonucleotide 
was 96% pure.  (B)  A single nucleotide incorporation reaction was performed under the 
same conditions as in (A), but quenched after 0.12 s reaction.  The duplex could not be 
eliminated by increasing the stringency of melting with higher percentages of formamide 
or an equal volume of 7-8 M urea. 
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Such long separation times present a problem for the method to compete with 
traditional PAGE.  Elimination of the contaminating duplex, allowed us to stack the 
samples onto the gel by sequentially injecting for 60 seconds, separating for 5 minutes, 
injecting again, and so on.  Figure 3.4 is a representative electropherogram of a 12-point 
time course for single nucleotide incorporation under burst conditions.  It shows a 
decrease in substrate and, concomitantly, an increase in product as a function of reaction 
time corresponding to the sequential injections.  The overall time required for this 
method, from quenching the last time point to resolving the time course, was 
approximately 3.5 hours.  The actual injection and separation time required for each 12-
point time course was 2.5 hours. 
We were concerned with possible interactions between the 5′-fluorescent label 
and the polymerase.  Results obtained using two commercially available labels differed 
kinetically when used in single nucleotide incorporation assays.  BodipyTM 630/650, 
which has a good signal when excited with the 635 nM laser, was linked to the 5′ end of a 
25mer primer and annealed to a 45mer template.  Figure 3.5 shows the results of two 
burst experiments performed in the presence of 100 nM Pol γ holoenzyme and 300 nM 
DNA reacting with 100 µM dTTP.  When fit to a burst equation, the rate of the burst was 
not significantly different from the experiment performed using the radiolabeled primer, 
but the amplitude of the reaction was only 30%.  The burst amplitude is important 
because it quantifies the concentration of active E-DNA complexes.  The underlying 
cause for the lower amplitude is unknown, but it seems logical that the highly 
hydrophobic label may interact with the polymerase to weaken the DNA binding affinity, 
interfere with proper alignment of the DNA on the enzyme, or both.  BodipyTM labeled 
DNA was abandoned at this time in the interest of finding a probe that gave results 
kinetically similar to those obtained using a radioactive label.  The possibility of an  
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Figure 3.4: Electropherogram of a 12-point burst experiment 
The separation of a 12-point pre-steady-state burst experiment (0 - 1.5 seconds) was 
carried out, where the samples were injected every 5 minutes, and then resolved 
sequentially.  With the elimination of duplex, the samples separated cleanly and were 
easily analyzed by integration (all points in a single electropherogram).  The single peak 
to the far left was a zero time point, where there was no DNAn+1.  In the following peaks 
there was a decrease in DNAn, and a corresponding increase in DNAn+1, until 

















Figure 3.5: BodipyTM 630/650 labeled primer showed a significant kinetic difference in a 
burst experiment 
Two burst experiments were performed under identical conditions (100 nM Pol γ 
holoenzyme and 300 nM DNA), except for the 5′-labels.  Parallel reactions were 
performed using radiolabeled primer (○) and a 5′-BodipyTM 630/650 label (●).  The rates 
are identical, but the reaction with the fluorescently labeled DNA had an amplitude of 




interaction between the label and the polymerase prompted a brief study probing for 
possible interactions with 5′-6-carboxyfluorescein (6-FAMTM) using the 488 nM laser.  
Along with a change in the 5′-label from BodipyTM to 6-FAMTM on the 25mer, two other 
primers were examined which were of differing lengths.  The sequences are shown in 
Figure 3.2; two were 27/45mers (one with a G:A mismatch at 3′ of the template), which 
have a two base pair overhang, one was a 23/45mer, which has a two base pair recessed 
end. 
Figure 3.6 shows the results of a series of pre-steady-state burst experiments 
under identical conditions, except for the sequence and length of the primers used.  The 
rates of the four were relatively normal, but there are significant differences in the 
reaction amplitudes.  The 25/45mer showed normal rate and amplitude.  The reason for 
lower amplitudes obtained with DNA containing an overhang and recessed ends was not 
examined because the 25/45mer DNA gave a promising result.  A parallel experiment 
performed with a radiolabeled primer is shown in Figure 3.7; the results obtained using 
the two methods were nearly identical.  Further experiments with this primer/template 
combination showed that single-turnover experiments (90 nM DNA) could be performed 
with accuracy (data not shown).  However, under the conditions outlined here, the limit 
of detection did not allow for accurate analysis of reactions containing concentrations less 
than 90 nM 5′-6-FAMTM labeled DNA (2.7 pmol primer per well). 
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Figure 3.6: Experiments with 5′-6-FAMTM-labeled DNA 
Four pre-steady-state experiments were performed under identical conditions, except for 
the DNA used.  Figure 1 depicts the particular sequence for experiments performed with 
a 23/45mer with a 5′-2 base recess (□), a 27/45mer with a 5′-AA overhang (■), or a 
27/45mer with a 5′-AA overhang and a G:A (●) and compared to an experiment  
performed with a radiolabeled 25/45mer (○), which showed the highest reaction 

















Figure 3.7: 5′-6-FAMTM labeled DNA compared to a radioactive control 
The two reactions were performed in parallel, under identical conditions, except that one 
was done using a 5′-6-FAM labeled 25/45mer (○), whereas the other was done 
traditionally with a 5′-32P-labeled 25/45mer (●).  The experiment with fluorescently 
labeled DNA had a rate of 26 ± 1 s-1 and an amplitude of 89 ± 1 nM, which was similar to 






We began this work with the goal of developing a method that would allow us to 
quickly and accurately analyze the products from single nucleotide incorporation 
experiments without using radiolabels. It was hoped that this would allow more complex 
experiments to be executed using multiple fluorescent reporters.  The main problem(s) 
we encountered were due to a fraction of the primer migrating in heteroduplex with the 
template, limiting sensitivity, and fluorophore-protein interactions.  Addition of excess 
unlabeled ssDNA complementary to the template freed the labeled primer, which, in turn, 
allowed injecting multiple samples and resolving them during a single separation.  While 
the sensitivity limited our ability to accurately analyze samples from reactions containing 
less than 90 nM 6-FAMTM labeled primer, it was sufficient to allow use of concentrations 
typically used with radiolabeled primer.  It may be possible to go to lower DNA 
concentrations than examined here by loading undiluted samples into the 96-well plate if 
the reaction volume is not a concern.  Furthermore, labels other than 6-FAMTM may give 
better signal, which was the case for BodipyTM 630/650 in these experiments, but it is 
important to be certain that the fluorescent label reports results comparable to the 
radioactive label.  Capillary life seemed to vary greatly, and with the small sample size, 
we can not reliably quote a figure, but it is possible for a capillary to last for one hundred 
12-point time course separations (1200 data points). 
The benefits of the method over traditional PAGE are numerous, in that, 
radioactive material is eliminated, one time course can be analyzed within 4 hours, 
samples can be retained much longer, it is far less labor intensive, and is dramatically less 
wasteful in terms of reagents and laboratory space.  It is likely that this method will be 
useful for many DNA and RNA polymerases, whether examining single, double, or triple 
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nucleotide incorporation reactions.  Multiple incorporation events are common when 
examining fidelity, where reaction times are much longer, such that, more than one 
mismatch can be formed.  In addition, the technique can be used to inspect the kinetic 




Chapter 4: Kinetics of AZTTP Incorporation by the Human 
Mitochondrial Polymerase γ 
INTRODUCTION 
Current treatments for HIV include various combinations of nucleoside analog 
reverse transcriptase inhibitors (NRTI), nonnucleoside RT inhibitors (NNRTI), protease 
inhibitors, and a fusion inhibitor.  Nucleoside analogs continue to be essential 
components of highly active antiretroviral therapy (HAART).  The major limiting aspects 
of current treatments are the ability of HIV to develop resistance on one hand and the 
toxicity of the nucleoside analogs on the other (32).  It has been established that 
mitochondrial dysfunction observed with the use of nucleoside analogs is largely a result 
of inhibition of Pol γ during mitochondria DNA replication.  There have been a variety of 
reports for the toxicity of 3’azido-2’,3’-dideoxythymidine (AZT) and not all agree on the 
site of toxicity, leading to some confusion in regard to the clinical side-effects observed 
for AZT (32). 
The incorporation of all nucleoside analogs examined, except AZTTP, exhibited a 
concentration dependent rate of incorporation.  For AZTTP incorporation the amplitude 
was dependent on concentration according to a hyperbolic relationship, but the rate 
remained approximately constant, which complicated our interpretation of AZT toxicity 
(32).  We proposed that phosphoryl transfer (k3) is reversibly linked to binding (kinetic 
mechanism shown in the introduction).  That is to say that phosphoryl transfer is 
reversible (pyrophosphorolysis) for AZTTP incorporation.  This is an interesting prospect 
given the fact that AZTTP is the second least toxic nucleoside analog according to our 
toxicity index (Figure 1.3) and could be valuable information to aid the design of novel 
low toxicity inhibitors with similar incorporation kinetics.  This chapter is devoted to 
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understanding the kinetics of incorporation of AZTTP by Pol γ and how it relates to the 
mitochondrial dysfunction observed. 
MATERIALS AND METHODS 
Nucleoside analog triphosphates 
AZTTP and d4TTP were obtained from Moravek Biochemicals (Brea, CA). 
AZATP, AZCTP, and AZGTP were purchased from TriLink Biotechnologies (San 
Diego, CA). 
Pol γ expression and purification 
Overexpression and purification of recombinant human Pol γ were previously 
described (11;12). Holoenzyme was reconstituted at a 1:5 ratio of catalytic subunit to 
accessory subunit. All of the studies on the kinetics of incorporation of nucleoside analog 
triphosphates were conducted using an exonuclease-deficient mutant (E200A). 
Preparation of DNA 
A DNA primer/template of 25 and 45 nucleotides, respectively, was employed for 
all experiments except when terminated with AZTMP or dTMP for pyrophosphorolysis 
reactions, in which case they were 26 and 45 nucleotides, respectively.  The primer 
sequence was 5′-GCCTCGCAGCCGTCCAACCAACTCA-3′, and the template sequence 
was 5′-GGACGGCATTGGATCGAGGXTGAGTTGGTTGGACGGCTGCGAGGC-3′, 
where the bold X in the template was modified to provide desired base pair for the 
particular experiment being conducted.  Primer was 5′-32P-labeled using T4 
polynucleotide kinase, according to the manufacturer’s instructions (Life Technologies, 
Gaithersburg, MD). The reaction was terminated by incubation at 95°C for 5 minutes, 
and excess nucleotide was removed using a Bio-Spin 6 column (BioRad, Hercules, CA).  
Primer was annealed to 45-mer template by combining at an equimolar ratio, heating to 
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95 °C, and slowly cooling to room temperature.  Primers containing 3′-terminal AZTMP 
were created to examine pyrophosphorolysis.  A polymerase reaction was performed 
using 1 µM HIV-1 RT, 3 µM duplex DNA (containing appropriate template base 
opposite the 26th primer position), and 50 µM AZTTP in standard reaction buffer (50 
mM Tris-Cl, pH 7.5, 100 mM NaCl, 2.5 m MgCl2).  The reaction mixture was incubated 
at 37 °C for 30 min, and then the product was gel-purified to obtain the AZTMP-
terminated primer. Primer was labeled, and DNA duplex was annealed as described 
above. 
Incorporation and pyrophosphorolysis reaction conditions 
For reactions too fast to measure by benchtop mixing a quench-flow apparatus 
(RFQ-3) from KinTek Corp. (Austin, TX) was used.  All incorporation assays were 
performed at 37oC in a buffer containing 50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 2.5 mM 
MgCl2.  In some reactions MgCl2 was substituted by MnCl2 as noted in the text and 
Figure legends.  The Pol γ holoenzyme was reconstituted by incubating the two protein 
subunits for 5 min on ice in reaction buffer lacking magnesium. DNA was then added to 
the proteins, and the mixture was incubated for an additional 5 min on ice.  Incorporation 
reactions were initiated by the addition of nucleotide and magnesium in the same reaction 
buffer at 37 °C and then quenched with 0.5 M EDTA. Alternatively, the 
pyrophosphorolysis reactions were initiated by the addition of PPi and magnesium.  All 
concentrations given are concentrations after mixing.  Products were separated on 15% 
denaturing polyacrylamide sequencing gels, imaged on a phosphorimager, Molecular 
Dynamics Storm 860, and quantified using ImageQuaNT software (Amersham 
Biosciences, Uppsala, Sweden).   
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Kd and maximum rate of incorporation for nucleoside analogs or dTTP 
Single nucleotide incorporation assays were performed with various 
concentrations of analog to examine the nucleotide concentration dependence of 
incorporation rate or amplitude.  Single-turnover conditions were employed where the 
concentration of enzyme was greater than the concentration of DNA. Specific reaction 
conditions are listed in each Figure legend.  A time course was performed for each 
concentration of nucleotide or analog.  To normalize data, the integrated amount of 
product (DNAn+1) was divided by the sum of the substrate and product (DNAn + DNAn+1) 
and multiplied by the concentration of DNA used in the experiment.  The concentration 
of extended product 26mer DNA was plotted against time and fit to a single ([product] = 
A1*e-k1t +C), double ([product] = A1*e-k1t + A2*e-k2t + C), or triple ([product] = A1*e-k1t + 
A2*e-k2t + A3*e-k3t + C) exponential equation (as described in the Figure legends and 
results section).  The observed amplitudes were then plotted against nucleotide or analog 
concentrations, and the data were fit to a hyperbola (observed rate (or amplitude) = kpol 
(or Amax) * [dNTP]/(Kd + [dNTP]) to obtain the Kd and kpol or maximum amplitude 
(Amax) for each nucleoside analog triphosphate or dTTP.  For cases where the rate was 
not dependent on the concentration of the nucleotide analog, the rate was estimated by 
the reaction rate at the higher concentrations where a higher amplitude allowed a more 
accurate rate measurement. 
Determination of Kd by competition with dTTP  
Single exponential rates of dTTP incorporation in the presence of AZTTP were plotted as 
a function of AZTTP concentration.  The data were first fit to a hyperbola and then 




Stopped-flow measurement of PPi release 
A SF 2004 series stopped-flow apparatus from KinTek Corp. (Austin, TX) was 
used for the measurements.  Exonuclease-deficient holoenzyme (100 nM) was 
preincubated for 5 minutes with 2.5 mM Mg+2, 90 nM 25/45mer DNA, 1.5 µM E. coli 
phosphate binding protein (PBP) mutant labeled at Cys197 with N-[2-(1-
maleimidyl)ethyl]-7-(diethylamino)coumarin-3-carboxamide (MDCC), 100 µM 7-
methylguanosine, 0.02 units/mL purine nucleotide phosphorylase, and 0.005 units/µL 
pyrophosphatase.  The solution was then rapidly mixed in the stopped flow apparatus at 
20oC with 2.5 mM Mg+2, 50 µM dTTP, 100 µM 7-methylguanosine, and 0.02 units/mL 
purine nucleotide phosphorylase.  The sample was excited at 425 nm and a 450 nm long 
pass filter was used to observe emission.  The enzyme coupled assay for phosphate 
detection was previously established (80).  Control experiments verified that the rate of 
conversion of pyrophosphate to phosphate by pyrophosphatase was faster than the 
observed reaction. 
Synthesis of γ 32P labeled AZTTP 
Nucleoside diphosphate kinase (NDP kinase) was purchased from Sigma Aldrich 
Corp. (St. Louis, MO).  γ 32P-labeled ATP was from Perkin Elmer (Wellesley, MA).  
AZTDP was purchased from Moravek Biochemicals (Brea, CA).  The reaction was 
carried out in standard Pol γ buffer at room temperature for 1 hour with 600 nM γ 32P-
labeled ATP (3000 Ci/mmol), 600 nM AZTDP, and 0.1 units/µL NDP kinase, at which 
time, conventional rat kinesin was added to a final concentration of 5 µM to rid the 
reaction of unreacted γ 32P-labeled ATP.  The sample was loaded onto a 1 mL DEAE 
Sepharose FF (Amersham Biosciences (Piscataway, NJ)) column at flow rate of 1 
mL/min and a gradient of 0.1-1M triethylammonia (pH 7.5) was run to elute γ 32P-labeled 
AZTTP.  Elution of product was monitored by counting 10 µL of each fraction using a 
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scintillation counter.  Peak fractions were lyophilized and resuspended in 10 mM Tris-Cl, 
pH 7.5.  Labeled and unlabeled AZTTP were combined at a ratio of 1:10,000 for a stock 
concentration of 3 mM. 
Measurement of PPi release during AZTTP incorporation 
Reactions were performed by manual mixing on the benchtop under single-
turnover conditions (exact reaction conditions are listed in the Figure legend).  The Pol 
γ/DNA complex was mixed with γ 32P-labeled AZTTP and Mg+2 to start the reaction.  At 
each time point a 40 µL aliquot was taken and passed through a BioSpin 30 (BioRad, 
Hercules, CA) gel filtration column by centrifuging for 30 seconds @ 4,000 RPM.  The 
elution from each time point was spotted onto a PEI Cellulose F 20 × 20 cm glass backed 
TLC plate (EM Science) along with a standard curve of various amounts of γ 32P-labeled 
AZTTP to generate a standard curve.  Imaging was performed using a phosphorimager, 
Molecular Dynamics Storm 860, and quantified using ImageQuaNT software (Amersham 
Biosciences, Uppsala, Sweden). 
RESULTS 
AZTTP incorporation by Pol γ 
Shown in Figure 4.1A are the results of a single-turnover experiment, starting 
with a preincubated solution of exonuclease-deficient Pol γ and 25/45mer DNA substrate 
(single T incorporation) and rapidly mixed with increasing concentrations of AZTTP. 
This experiment is a repeat of an experiment already published and was an effort to 
obtain more accurate data (32). Again, it was the amplitude that was dependent on the 
concentration of nucleotide used (Figure 4.1B).  However, the rate of incorporation 
decreased as the concentration of AZTTP increased (Figure 4.1C).  The dependence of 
the amplitude on concentration was fit to a hyperbola using non-linear regression yields a 
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Kd of 160 ± 40 µM.  A kpol of 0.2 s-1 can be estimated from the rate of incorporation at 
higher concentrations of AZTTP.  The rates obtained at lower amplitudes exhibit 
relatively high errors because the total product formation is approaching the experimental 
limit for accurate analysis. 
Pyrophosphorolysis of AZTMP 
The most direct method to examine the possibility of pyrophosphorolysis 
occurring during AZTTP incorporation was to perform the reaction in the reverse 
direction.  For this experiment a 26mer primer 3′-terminated with AZTMP was annealed 
to a 45mer template.  It was expected that pyrophosphorolysis would be observed by 
mixing the Pol γ/DNA complex with various concentrations of PPi.  To the contrary, no 






















































Figure 4.1: Kinetics of incorporation of AZTTP by Pol γ 
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and then rapidly mixed with Mg+2 and various concentrations of AZTTP (25 (○), 75 
(●), 150 (□), 250 (■), 375 ( ), and 500 µM ( )). Each data set was fit to a single 
exponential to obtain the amplitude of the single exponential.  (B) The single exponential 
amplitudes were plotted as a function of AZTTP concentration. The fit of the data to a 
hyperbola yields a Kd of 160 ± 40 µM. (C) The single exponential rates were plotted 
against AZTTP concentration.  The maximum polymerization rate of 0.2 s-1 was 
estimated from the rate of incorporation at higher AZTTP concentrations. 
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Figure 4.2: Pyrophosphorolysis reaction of AZTMP-terminated primer 
Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 26/45mer 
DNA terminated with AZTMP and mixed with Mg+2 and various concentrations of PPi as 
depicted in the gel image.  No Pyrophosphorolysis was observed in reactions carried out 





The lack of detectable pyrophosphorolysis using an AZTMP-terminated primer did not 
agree with our hypothesis of reversible phosphoryl transfer and prompted an experiment 
designed as a positive control using a primer terminated with the natural nucleotide, 
dTMP. 
Pyrophosphorolysis of dTMP 
An experiment was performed under conditions similar to the previous 
experiment, except that the primer was designed to be a 26mer, with dTMP at the 3′- 
terminus.  Figure 4.3A shows the result of the experiment performed by mixing a 
preformed complex of Pol γ and dTMP-terminated DNA with increasing concentrations 
of PPi.  It is apparent in the upper left hand time course designated "0 mM PPi", there 
was a slow rate of background degradation of the primer.  In reactions containing PPi, the 
rate of loss of substrate (26mer) increased along with apparent extension of the substrate, 
indicating the production of dNTP as a result of pyrophosphorolysis during the course of 
the reaction.  It was not a surprise that pyrophosphorolysis would occur with a naturally 
terminated primer as it has been previously accomplished using T7 DNA polymerase 
(22).  The time course of loss of substrate for each concentration of PPi was fit to a single 
exponential (Figure 4.3B) and the rates obtained were plotted versus pyrophosphate 
concentration and fit to a hyperbola plus a constant.  The constant was included to 
account for the rate of degradation of the 26mer with no pyrophosphate present (Figure 
4.3C).  The maximum rate of pyrophosphorolysis was 0.75 ± 0.09 s-1 and the Kd was 80 ± 
65 µM.  The pyrophosphorolysis reactions did not go to completion due to the formation 




































igure 4.3:  Pyrophosphorolysis of dTMP-terminated primer 
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Figure 4.3:  Pyrophosphorolysis of dTMP-terminated primer 
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 26/45mer 
DNA terminated with dTMP and was mixed with Mg+2 and various concentrations of PPi 
(depicted on the phosphorimage of the gel.).  Reactions were carried out for 25 seconds.  
It is apparent from the gel that pyrophosphorolysis is occurring due to the accumulation 
of both shorter and longer DNA products.  Longer products could only be a result of 
pyrophosphorolysis because of the production of the dNTP during the reaction.  (B) The 
concentration of substrate 26mer was plotted as a function of time and fit to a single 
exponential equation to obtain the reaction rates.  Each reaction was performed at a 
different concentration of PPi (0 ( ), 0.1 ( ), 0.25 ( ), 0.5 ( ), 1 ( ), 3 ( ), 5 ( ), and 
10 ( ) mM.  (C) The reaction rates were plotted versus the concentration of PPi used in 
the experiment and fit to a hyperbola (plus a constant) to yield a Kd of 80 ± 65 µM, a 
maximum rate of pyrophosphorolysis of 0.75 ± 0.09 s-1, and a background rate of 




AZTTP incorporation in the presence of PPi or pyrophosphatase 
Another approach used to examine the role of pyrophosphate in the 
polymerization reaction with AZTTP was to either include or exclude pyrophosphate 
from solution during the incorporation reaction.  To exclude pyrophosphate from 
solution, we included a sufficient concentration of yeast pyrophosphatase in the reaction 
mixture to convert pyrophosphate to phosphate within the time scale of the experiment.  
The time dependence of polymerization in the presence of yeast pyrophosphatase was 
identical to the control experiment (Figure 4.4A).  In AZTTP incorporation reactions 
where pyrophosphatase was replaced with increasing concentrations of pyrophosphate, 
no significant decrease in the amplitude of the reaction was observed until the 
concentration reached 100 µM (Figure 4.4A).  However, at PPi concentrations near that 
expected to be formed during the incorporation reaction (~40 nM), there was no 
statistically significant difference in the data obtained in the presence or absence of PPi.  
A reduction in the amplitude of incorporation at concentrations of 100 µM or greater was 
likely to be the result of degradation of substrate 25mer at a rate comparable to the rate of 
incorporation of AZTTP (Figure 4.4B). 
Hydrolysis of AZTTP in the active site 
Unable to observe a role for pyrophosphorolysis on the concentration dependent 
amplitude of incorporation of AZTTP from the above experiments, we believed a 
different approach was needed.  Rather than the enzyme catalyzing the 
pyrophosphorolysis reaction at a rate fast enough to explain our results, we considered 
the possibility that AZTMP was hydrolyzed from the primer at a substantial rate in the 
active site.  Instead of AZTTP returning to solution due to pyrophosphorolysis after 
incorporation, AZTMP would accumulate as the product of an enzyme catalyzed 
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hydrolysis reaction.  In order to test this postulate, a single-turnover experiment was 
performed at a concentration of 75 µM AZTTP.  At zero time an aliquot was taken and 
separated using a salt gradient on a DEAE column, measuring absorbance at 254 nm 
(Figure 4.5A).  The longest time point analyzed was carried out to 110 minutes and did 



































Figure 4.4:  Incorporation of AZTTP in the presence of PPi or pyrophosphatase  
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and mixed with Mg+2 and 200 µM AZTTP alone (●) or in the presence of 0.5 units 
of yeast pyrophosphatase (○), or varying concentrations of PPi (0.2 (■), 1 (□), 100 ( ), 
or 500 ( ) µM).  Including pyrophosphatase in the reaction had little to no effect.  Only 
in reactions containing 100 or 500 µM PPi was the amplitude reduced, which was likely 
due to the loss of 25mer substrate DNA in the reaction at about the same rate as the 
incorporation of AZTMP (~0.2 s-1).  (B) Shown is a plot of the amount of 25mer during 
the course of the reactions containing 100 (●) and 500 (○) µM PPi.  A fit to a single 















Figure 4.5:  Hydrolysis of AZTTP during incorporation reaction 
(A) Exonuclease-deficient holoenzyme was preincubated with 90 nM 25/45mer DNA and 
mixed with Mg+2 and 75 µM AZTTP.  The trace shown is a gradient elution (0.02-1M 
NaCl in 0.02M tris-hydroxymethylaminoethane (Tris) buffer, pH 7.7 @ 4oC) of the 
reaction at zero time from a DEAE fast flow chromatography column measuring 
absorbance at 254 nm.  Control experiments of AZTTP and AZTMP showed that the 
peak labeled is AZTTP (Data not shown).  (B) A trace of a reaction stopped at 110 
minutes under the same experimental conditions as (A) shows that the AZTTP used in the 
reaction was not hydrolyzed to AZTMP. 
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dTTP chase experiment 
To examine the amount of enzyme/DNA complex at equilibrium during AZTTP 
incorporation, a chase experiment was designed, where a single-turnover reaction with 
AZTTP was carried out for 15 second (long enough to reach equilibrium), then dTTP was 
added and a reaction time course was taken.  Since AZTTP incorporation was at 
equilibrium at the time of the dTTP addition, any immediate product formation had to be 
occurring with enzyme/DNA complex that was free of AZTTP (Figure 4.6).  According 
to the Kd for DNA binding, and many previous single-turnover experiments (correct 
incorporation reactions with 100 nM holoenzyme and 90 nM DNA), an amplitude of 60 
nM is normal.  The first time point taken after the addition of dTTP was at two seconds, 
at which time, the amount of product was 60 nM, which can be interpreted as the sum of 
AZTMP and dTTP incorporation.  If the amount had been significantly lower than 60 
nM, then our approximation of the Kd for AZTTP binding would have been incorrect.    
The seemingly linear increase in the amount of product formed over time after the 
addition of dTTP is due to the binding of free enzyme and un-reacted DNA followed by 
incorporation and precludes any detailed analysis. 
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Figure 4.6:  AZTTP incorporation followed by a chase with TTP 
Two reactions were performed in parallel for this experiment: First, exonuclease-
deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer DNA and then 
mixed with Mg+2 and 200 µM AZTTP and allowed to react for up to 30 seconds for a 
control (●), Second,: the same starting reaction conditions as in the control was allowed 
to react for 15 seconds with 200 µM AZTTP and a single time point taken ( ) at which 
time 50 µM dTTP was added and allowed to react for two seconds before the first time 
point was taken (corresponding to 17 seconds on the graph)(○).  The amount of product 2 
seconds after the addition of dTTP was about 60 nM, and illustrates that there was about 




Determination of the Kd for AZTTP by competitive inhibition 
An additional method was employed in order to determine the Kd for AZTTP 
binding, because of the unusual way in which the Kd was obtained previously.  An 
unambiguous measurement of the Kd was performed by direct competition of dTTP and 
AZTTP.  In order to accomplish this, we measured the rate of dTTP incorporation in the 
presence of varying concentrations of AZTTP under single-turnover conditions (Figure 
4.7A).  This was possible because of the large difference between the maximum rates of 
incorporation (25 s-1for dTTP and 0.2s-1 for AZTTP).  The Kd determined was 30 ± 16 
µM, and was about 5-fold tighter than the Kd obtained earlier (160 ± 40 µM) by fitting 
the amplitude dependence (Figure 4.7B).  The underlying reason for such a tight true Kd 
cannot be explained at this time and may require further investigation. 
Incorporation of dTTP in the presence of Mn+2
Mn+2 has been shown to dramatically reduce the fidelity of DNA polymerases and 
is the basis for error prone PCR.  Neither correct nor incorrect incorporation had been 
studied with Pol γ using Mn+2 instead of Mg+2; therefore, we felt it to be a worthwhile 
endeavor to examine the incorporation of dTTP and AZTTP with manganese present.  It 
was thought that substitution of the divalent cation could help clarify the abnormal 
incorporation kinetics of AZTTP.  Under single-turnover conditions, we measured 
product formation for dTTP incorporation as a function of time at a final Mn+2 
concentration of 2.5 mM (Figure 4.8A).  The data from the four highest concentrations of 
dTTP were best fit to a double exponential equation, whereas the data from the lower two 
dTTP concentrations were fit with a single exponential equation.  The rate of the fast 
phase of incorporation from the four highest concentrations of dTTP and the rate from the 
two lower concentrations (single exponentials) were plotted versus dTTP concentration 
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and fit to a hyperbola (Figure 4.8B) to obtain a kpol of 170 ± 20 s-1, and a Kd of 3.6 ± 0.7 
µM.  The reason underlying the two phase reaction is unknown, but is likely the result of 
a small amount of free enzyme and DNA (according the Kd for DNA binding) at the start 
of the reaction and going on to react more slowly as a function of the rate of DNA 
binding.  At lower concentrations of dTTP the two phases of the reaction were not 
resolved and the resulting single exponential rate is, in essence, an average of the two 
unresolved phases.  One interesting result not expected from this experiment was the 
dramatic rate enhancement from 25 s-1 in the presence of Mg+2 to 170 s-1 in the presence 
of Mn+2.  However, the ground state dissociation constant increased by about the same 
magnitude resulting in no overall change in the specificity constant (Table 4.1). 
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Figure 4.7:  Determination of the Kd for AZTTP by competitive inhibition  
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and then rapidly mixed with Mg+2, 1 µM dTTP and various concentrations of 
AZTTP (0 (○), 50 (●), 200 (□), and 400 (■) µM). Each data set was fit to a single 
exponential to obtain the rate of the single exponential.  (B) The single exponential rates 
were plotted as a function of AZTTP concentration. Data were fit to a hyperbola to obtain 
an apparent Kd of 76 ± 42 µM and analyzed with the equation 
Kdapp=KdAZTTP(1+([dTTP]/KddTTP)), defining competitive inhibition parameters to yield a 



































Figure 4.8:  Incorporation of dTTP in the presence of Mn+2 
(A) Exonuclease-deficient holoenzyme (150 nM) was preincubated with 140 nM 
25/45mer DNA and then rapidly mixed with 2.5 mM Mn+2 and various concentrations of 
dTTP (0.5 (○), 0.75(●), 1(□), 2(■), 5( ), and 20 µM ( )). Each of the four highest data 
sets were fit to a double exponential to obtain the rates of incorporation, but the lower 
two concentration data sets were best fit to a single exponential.  (B) The fast phase of the 
double exponential fits (highest four concentrations of dTTP) and the single exponential 
rates (lowest two concentrations of dTTP) were plotted as a function of dTTP 
concentration(○) and a fit of the data to a hyperbola yields a Kd of 3.6 ± 0.7 µM and a 
maximum rate of incorporation of 170 ± 20 s-1.  The slow phases are nearly constant, at a 




Incorporation of AZTTP in the presence of Mn+2
Single-turnover experiments were performed exactly as in the previous 
experiment, but with AZTTP (Figure 4.9A).  Of significance, unlike incorporation of 
AZTTP in Mg+2 where the amplitude was dependent on concentration, the rate varied 
with concentration of AZTTP incorporation with Mn+2 present (Figure 4.9B).  Data were 
fit to a hyperbola to obtain a Kd of 23 ± 5 µM and a kpol of 0.043 ± 0.004 s-1.  The trend of 
faster incorporation and looser binding for dTTP (Mn+2 versus Mg+2) was reversed in the 
case of AZTTP.  The rate for AZTTP incorporation in the presence of Mn+2 was 5-fold 
slower and the Kd 7-fold tighter compared to incorporation in the presence of Mg+2, 
resulting in no statistically significant change in specificity constants (Table 4.1).  A 
change from a concentration dependent amplitude of incorporation in the presence of 
Mg+2 to a concentration dependent rate of incorporation in the presence of Mn+2 is not 
fully understood, but suggests that there may be an unusual interaction between the azide 
group and Mg+2 or other metal ion-dependent change in the interaction of AZT with the 
enzyme. 
Discrimination against AZTTP in the presence of Mn+2
Surprisingly, discrimination against AZTTP is not greatly reduced when the 
incorporation reaction is performed in the presence of Mn+2 compared to Mg+2 (32,000 
and 25,000, respectively) (Table 4.1).  A discrimination of 32,000 predicts that, at equal 
concentrations of dTTP and AZTTP, Pol γ is 32,000 times more likely to insert the 
natural nucleotide.  The fact that we did not see a large reduction in discrimination 
against AZTTP in the presence of Mn+2 is puzzling, and may warrant further 
investigation.  Other polymerases, notably T7, Taq, and  Klenow show a marked 




      kpol (s-1)         Kd (µM)     Specificity (kpol/Kd)              Discriminationa
25 ± 2 0.6 ± 0.2 42±  14 
~0.2b 160 ± 40 0.0013 ± 0.0003 
32000 





AZTTP/Mn+2 0.043 ± 0.004 23 ± 5 0.0019 ± 0.0004 
25000 
a  Discrimination = (kpol/Kd)correct/(kpol/Kd)analog, where the values for dTTP incorporation in the presence of 
Mg+2 were taken from Ref (19) 
b  A value of 0.2 s-1 was estimated from the rate of incorporation at higher concentrations of AZTTP. 
Table 4.1:  Comparison of the incorporation of dTTP and AZTTP in the presence of Mg+2 
and Mn+2
Data obtained from the incorporation reactions with the natural nucleotide dTTP in the 
presence of Mg+2 and Mn+2 are compared to data obtained from the incorporation of 
AZTTP in the presence of Mg+2 and Mn+2.  Surprisingly, discrimination against AZT is 
not greatly reduced when the incorporation reaction is performed in the presence of Mn+2. 
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Figure 4.9:  Incorporation of AZTTP in the presence of Mn+2 
(A) Exonuclease-deficient holoenzyme (150 nM) was preincubated with 140 nM 
25/45mer DNA and then rapidly mixed with 2.5 mM Mn+2 and various concentrations of 
AZTTP (10 (○), 75 (●), 150 (□), 300 (■), and 500 ( ) µM).  Each data set was fit to a 
single exponential to obtain the rate of incorporation.  (B) The single exponential rates of 
incorporation were plotted as a function of AZTTP concentration (●) and a fit of the data 




Incorporation of d4TTP in the presence of Mn+2
The thymidine analog d4T has been approved by the FDA for use in the treatment 
of HIV.  Structurally, d4T differs from thymidine and AZT only on the 2′ and 3′ carbons.  
d4T has no functional group on the 3′ carbon, but rather has a double bond connecting the 
2′ to the 3′ carbon.  This structural similarity gave us the opportunity to examine the 
incorporation of d4TTP in the presence of Mn+2, in an attempt to better understand the 
results obtained with AZTTP.  The result of a single-turnover experiment is shown in 
Figure 4.10A.  The amplitude of the reaction is dependent upon concentration of d4TTP 
reveals a hyperbolic relationship, but in this case the substoichiometric concentration of 
d4TTP used in the experiment limits overall product formation. (Figure 4.10B).  The 
amplitude of the reaction was fit to a quadratic to yield a Kd of 3 ± 5 nM.  A plot of the 
rate of reaction against d4TTP concentration is fairly linear, also signifying an extremely 
tight Kd (Figure 4.10B).  Under the conditions we normally use to measure ground state 
dissociation constants for nucleotides, it is difficult to obtain reliable data for such tight 
binding substrates.  However a fairly accurate assessment of the maximum rate of 
incorporation can be estimated from the data and is approximately 2 s-1.  Using these 
values and comparing them to data obtained for the incorporation of d4TTP in the 
presence of Mg+2 (32), the Kd is about 15-fold tighter and the kpol is about 8-fold faster 
resulting in about an 120-fold reduction in discrimination against d4TTP (0.1).  This 
result contrasts with the largely unchanged discrimination against AZTTP in the presence 
of Mn+2 versus Mg+2. 
 
Time (s)





















































Figure 4.10:  Incorporation of d4TTP in the presence of Mn+2
(A) Exonuclease-deficient holoenzyme (150 nM) was preincubated with 140 nM 
25/45mer DNA and then rapidly mixed with 2.5 mM Mn+2 and various concentrations of 
d4TTP (0.005 (○), 0.01 (□), 0.025 (●), 0.1 (■), 0.3 ( ), and 50 ( ) µM).  Each data set 
was fit to a single exponential to obtain the rate and amplitude of incorporation.  (B) The 
amplitudes were plotted as a function of d4TTP concentration and fit to a quadratic 
equation to obtain a Kd of 3 ± 5 nM..  The maximum obtainable amplitude was limited by 
the amount of d4TTP added to the reaction at low concentrations and is so tight that it is 
difficult to measure using this technique.  (C) The rate of incorporation was plotted as a 
function of d4TTP concentration.  The rates were more or less linear with concentration, 
which likely means that, at concentrations of d4TTP required to obtain lower rates of 
incorporation, there is too little product for measurement. 
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Steady-state kinetic parameters for the incorporation of AZTTP 
We measured the steady-state kinetic parameters for AZTTP incorporation 
because it is possible that the steady-state kinetic parameters could reveal a change on the 
overall rate-limiting step of the reaction compared to correct nucleotide incorporation.  
Since we were unable to observe the reverse reaction by adding PPi to a preformed 
complex of enzyme/DNA (terminated with AZTMP), it is likely that a step following 
phosphoryl transfer is not readily reversible.  The most likely explanation for the reaction 
to appear reversible regarding the incorporation reaction (amplitude dependence) but not 
be able to observe the reverse reaction is that the conformational change (opening of the 
enzyme) after phosphoryl transfer may not be occurring at a fast rate.  If the enzyme 
remains in the closed conformation after AZT incorporation and the rate of opening is 
slower than DNA release then the steady-state rate may be slowed in comparison to DNA 
release during a correct nucleotide incorporation reaction.  Shown in Figure 4.11A is the 
result of a steady-state experiment in which increasing concentrations of AZTTP were 
added to a reaction with DNA in a 15-fold molar excess over enzyme.  A plot of rate 
versus AZTTP concentration follows a Michalis-Menton relationship of initial velocities 
and was fit to the hyperbola to obtain a kcat of 0.001 ± 0.0001 s-1 and a Km of 280±70 µM 
(Figure 4.11B).  Significantly, the kcat of 0.001 s-1 for AZTTP incorporation was 20-fold 
slower than the kcat of 0.02 s-1 for a correct incorporation under the same conditions (12).  
It is important to note that the incorporation of AZTTP under single turnover conditions 
occurs at a 200-fold faster rate (0.2 s-1) than the kcat, which likely means that there is a 
step following phosphoryl transfer that is rate limiting in the steady-state.  The rate-
limiting step is most likely the conformational change following phosphoryl transfer or 






























Figure 4.11:  Steady-state incorporation of AZTTP  
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 1.5 µM 
25/45mer DNA and mixed with Mg+2 and various concentrations of AZTTP (50 (○), 100 
(●), 200 (□), 300 (■), 400 ( ), and 500 ( ) µM).  Data obtained was fit by linear 
regression and the slope divided by enzyme concentration to obtain the rate of turnover.  
(B) The rate of turnover was plotted against AZTTP concentration and data were fit to 
the Michalis-Menton equation to obtain Km and kcat values.  The Km for AZTTP 
incorporation was found to be 280±70 µM and the kcat was 0.001 ± 0.0001 s-1.  The value 
of 0.001 s-1 for kcat was 20-fold slower than the rate of dissociation of the enzyme/DNA 




AZTMP-terminated DNA dissociation 
To get a better grasp on the basis for the reduced steady-state rate of AZTTP 
incorporation as compared to that for a natural nucleotide, we attempted to measure the 
release from the enzyme active site of DNA terminated with AZTMP.  Two separate 
experiments were performed: (1) Pol γ, was mixed with excess DNA (radiolabeled), the 
correct nucleotide (dCTP in this case), and Mg+2 (Figure 4.12A) to measure the steady-
state rate of incorporation; and (2) Pol γ was preincubated with a 2-fold excess of 
AZTMP-terminated DNA (non-radiolabeled) before mixing with the same contents as in 
(1).  The first reaction was performed in order to obtain an expected value for the steady-
state rate of turnover while the second reaction was limited by the rate of release of AZT-
terminated DNA from the enzyme (Figure 4.12B).  In the second reaction starting with a 
preincubated solution of Pol γ and AZT-terminated DNA, one might expect to see a lag 
defining an exponential increase in the steady-state turnover rate as the reaction 
proceeded, because of the dissociation of the enzyme/AZTMP-terminated DNA complex 
leading to free enzyme to catalyze incorporation onto the excess labeled DNA template.  
Product formation for the first experiment was plotted versus time and fit to a burst 
equation to obtain the rate and amplitude of the burst phase and also the linear steady-
state rate.  The amplitude of burst phase was 87 ± 3 nM (100 nM enzyme was used in the 
reaction) and the rate was 2.5 ± 0.2 s-1.   The steady-state rate was obtained by dividing 
the slope of the linear phase by the enzyme concentration and was 1.24 ± 0.5 s-1. The 
turnover rate for the reaction containing AZT-terminated DNA was linear with a rate of 
0.08 ± 0.004 s-1.  This slow linear rate of product formation in the experiment can be 
accounted for as a function of the 6 nM free enzyme during the experiment, calculated by 
dividing the turnover rate of the control experiment by the turnover rate of the experiment 
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containing AZT-terminated DNA.  Computer simulation of this experiment shows that 
the rate of AZTMP-terminated DNA dissociation from the enzyme is likely to be less 
than 0.004 s-1, but cannot be assigned a definitive value. 
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Figure 4.12:  Dissociation of enzyme from DNA terminated with AZTMP  
(A) Exonuclease-deficient holoenzyme (100 nM) was rapidly mixed with Mg+2, 5 µM 
dCTP, and 2 µM 25/45mer DNA (coding for dCTP incorporation).  Product formation for 
the control was plotted versus time and fit to a burst equation to obtain the rate and 
amplitude of the burst phase and also the linear steady-state rate.  The amplitude of burst 
phase was 87 ± 3 nM and the rate was 2.5 ± 0.2 s-1.   The steady-state rate was obtained 
by dividing the slope of the linear phase by the enzyme concentration and was 1.24 ± 0.5 
s-1.  The dashed line is the linear fit of the data in the following experiment.  (B) 
Exonuclease-deficient holoenzyme (100 nM) preincubated with 200 nM 26/45mer 
terminated with AZTMP was rapidly mixed with Mg+2, 5 µM dCTP, and 2 µM 25/45mer 
DNA (coding for dCTP incorporation).  Product formation was plotted versus time and 
was fit by linear regression to obtain the slope.   The steady-state rate was obtained by 
dividing the slope of the linear phase by the enzyme concentration and was 0.08 ± 0.004 
s-1.  A linear rate instead of an exponential increase in rate signifies that little to none of 
the enzyme in complex with AZTMP-terminated DNA dissociated (becoming free to 




Rate of pyrophosphate release during dTTP incorporation 
From previous experiments it was established that the rate of dissociation of 
AZTMP-terminated DNA from Pol γ was slower than expected regardless of whether PPi 
was present in the active site.  Therefore, it was of interest to measure the rate of PPi 
release from Pol γ during both dTTP and AZTTP incorporation reactions.  To measure 
PPi release during dTTP incorporation we designed an experiment taking advantage of 
MDCC-labeled phosphate binding protein (PBP), which exhibits large fluorescence 
increase upon phosphate binding (80).  PPi does not induce a fluorescence change with 
MDCC-labeled PBP, so PPi was hydrolyzed to phosphate (Pi) during the reaction with a 
high concentration of yeast pyrophosphatase.  Because Pi is a wide spread contaminant, a 
"Pi mop" consisting of 7-methylguanosine and purine nucleoside phosphorylase was used 
to reduce the concentration of contaminant Pi for each experiment (80).  The first 
experiment was done with dTTP to get the results shown in Figure 4.13.  The data 
obtained from 7 individual time traces was averaged and fit to a triple exponential 
equation by nonlinear regression.  The three phases of the exponential, starting with the 
fast phase, had rates of 15 ± 0.08 s-1, 0.722 ± 0.007 s-1, and 0.060 ± 0.001 s-1, respectively 
(Figure 4.13A).  The first two phases of the reaction can be accounted for by our 
knowledge of this reaction.  The first phase is likely the rate of release of PPi as a 
function of the rate of dTTP incorporation and the second phase is a function of the rate 
of free enzyme and DNA binding since under these conditions enzyme is not completely 
saturated with DNA upon mixing.  We do not know what the third phase of the reaction 
represents.  The amplitude of the fast phase of the reaction was determined to be 54 nM 
by using a PPi standard curve performed in the stopped-flow on the same day of the 
experiment (Figure 4.13B).  As a control experiment, a reaction using radiolabeled DNA 
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was performed in the quench-flow under the same conditions (superimposed on the 
stopped-flow data Figure 4.13A).  The data also fit a triple exponential.  The three phases 
of the exponential had rates of 22 ± 2 s-1, 0.9 ± 0.3 s-1, and 0.09 ± 0.09 s-1, respectively.  
Correspondingly, amplitudes of the three phases were 33 ± 2 nM, 13 ± 2 nM, and 20 ± 4 
nM, respectively.  The differences in the rates and amplitudes of the two experiments 
stems from the difficulty of measuring a triple exponential reaction in the quench-flow 
apparatus where the three phases are not defined well, but the rate of the fast phase of the 
two experiments agree fairly well (15 s-1 in the stopped-flow and 22 s-1 in the quench-
flow).  It is likely that the slower rate obtained in the stopped-flow was due to the slightly 
larger amplitude of the fast phase (54 versus 33 nM), which would account for a 
reduction in the rate.  These data indicate that PPi release is fast following incorporation.  
Similar experiments were performed with AZTTP but failed, for reasons stated below. 
Rate of pyrophosphate release during AZT incorporation 
To examine the rate of release of pyrophosphate by Pol γ during the slower 
AZTTP incorporation reaction, a different experimental approach was needed.  γ-32P-
AZTTP was prepared from AZTDP using nucleotide diphosphate kinase and γ32P-ATP.  
A preincubated solution of enzyme/DNA (single-turnover conditions) was mixed with γ-
32P-AZTTP to start the reaction.  For each time point, an aliquot was taken and, as 
quickly as possible, centrifuged through a gel filtration column.  The elution was spotted 
onto a TLC plate prepared with a standard curve for absolute PPi concentration 
determination, and quantified by fluorography.  When passed through the gel filtration 
column, only the enzyme-bound PPi should be present in the elution.  As shown in Figure 
4.14 there is a transient rise and fall in the concentration of enzyme bound PPi.  The 
concentration of PPi in the elution was plotted versus time and fit to a double exponential 
equation.  The rate and amplitude of the fast phase were 1.2 ± 0.3 min-1 and 700 ± 70 nM, 
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respectively.  The rate and amplitude of the slow exponential decrease in product 
formation were 0.007 ± 0.002 min-1 and 700 ± 50 nM, respectively.  As evidenced by the 
data, PPi is not released from the active site during the incorporation of AZTTP (0.2 s-1).  
The release rate of PPi is 1700-fold slower than AZTTP incorporation. 
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Figure 4.13:  Rate of PPi release during dTTP incorporation  
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated for 5 minutes with 
2.5 mM Mg+2, 90 nM 25/45mer DNA, 1.5 µM E. coli PBP mutant labeled at Cys197 with 
MDCC, 100 µM 7-methylguanosine, 0.02 units/mL purine nucleotide phosphorylase, and 
0.005 units/µL pyrophosphatase and then rapidly mixed in the stopped-flow apparatus at 
20oC with 2.5 mM Mg+2, 50 µM dTTP, 100 µM 7-methylguanosine, and 0.02 units/mL 
purine nucleotide phosphorylase.  The sample was excited at 425 nm and a 450 nm long 
pass filter was used to observe emission.  The data obtained from 7 individual time traces 
was averaged and fit to a triple exponential equation by nonlinear regression.  The three 
phases of the exponential, starting with the fast phase, had rates of 15 ± 0.08 s-1, 0.722 ± 
0.007 s-1, and 0.060 ± 0.001 s-1, respectively.  Superimposed on the same graph is a 
control experiment performed in the quench-flow as follows (●). Identical conditions as 
in the stopped-flow, except that the reaction was done with radiolabeled DNA as the 
reporter.  Amount of product formation was plotted on the same graph and fit to a triple 
exponential equation to obtain rate and amplitude information.  The three phases of the 




amplitudes of 33 ± 2 nM, 13 ± 2 nM, and 20 ± 4 nM, respectively.  (B) Shown is a 
standard curve for determination of PPi concentration produced in the stopped-flow.  The 
reactions were performed under similar reaction conditions as above, except that dTTP 
was substituted with increasing concentrations of PPi.  Shown is a plot of the amplitude 
obtained in the individual time traces and plotted versus concentration of PPi (●).  The 
amplitude of the fast phase in (A) was determined to be 54 nM. 
 
Time (min)













Figure 4.14:  Rate of pyrophosphate release during AZT incorporation 
Exonuclease-deficient holoenzyme (1 µM) was preincubated with 900 nM 25/45mer 
DNA and mixed with Mg+2, 300 µM γ-32P-labeled AZTTP, then at each time point an 
aliquot was taken and passed through a gel filtration column.  The elution was spotted on 
a TLC plate and quantified by fluorography and compared to a standard curve to obtain 
absolute concentration of PPi remaining in the active site of the enzyme.  The amount of 
PPi in the elution was plotted versus time and fit to a double exponential equation.  The 
rate and amplitude of the fast phase were 1.2 ± 0.3 min-1 and 700 ± 70 nM, respectively.  
The rate and amplitude of the slow exponential decrease in product formation were 0.007 




Kinetics of incorporation of AZATP by Pol γ 
The interesting results obtained for AZTTP incorporation prompted a series of 
experiments examining 3′-azido-2′,3′-dideoxyadenosine-5′-triphosphate (AZATP), 3′-
azido-2′,3′-dideoxycytidine-5′-triphosphate (AZCTP), and 3′-azido-2′,3′-
dideoxyguanosine-5′-triphosphate (AZGTP) incorporation reactions.  Figure 4.15A 
shows the time dependent incorporation of AZATP under single-turnover conditions.  
The data were fit to a double exponential. The amplitude for fast phase of each reaction 
was plotted as a function of AZATP concentration and fit the hyperbola to obtain a Kd of 
800 ± 120 µM, which is about 4-fold greater than that of AZTTP (Figure 4.15B).  The 
rate of the fast phase of each reaction was plotted against AZATP concentration in Figure 
4.15C to illustrate that the trend for AZATP incorporation was similar to that of AZTTP.  
A maximum rate of polymerization of 0.75 s-1 was estimated from the rate of 
incorporation at higher AZATP concentrations.  One significant difference between 
AZATP and AZTTP incorporation is that AZATP incorporation was biphasic on the time 
scale examined.  The underlying reason for biphasic incorporation will be addressed in 
the discussion section. 
Kinetics of incorporation of AZCTP by Pol γ 
The incorporation of AZCTP followed a biphasic trend (Figure 4.16A) similar to 
that of AZATP, but a Kd of 96 ± 6 µM determined from a hyperbolic fit of the 
concentration dependent amplitude change was about 2-fold tighter (Figure 4.16B).  The 
maximum rate of incorporation, estimated from the rate of incorporation at higher 
concentrations of AZCTP was 2 s-1, which is over 2-fold faster than AZATP, and 10-fold 
faster than AZTTP incorporation. 
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Figure 4.15: Kinetics of incorporation of AZATP by Pol γ 
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and then rapidly mixed with Mg+2 and various concentrations of AZATP (50 (○), 
100 (●), 200 (□), 300 (■), and 400 µM ( )).  Each data set was fit to a double 
exponential.  (B) The amplitude for fast phase of each reaction was plotted as a function 
of AZATP concentration. A fit of the data to the hyperbola yields a Kd of 800 ± 120 µM. 
(C) The rate of the fast phase of each reaction was plotted against AZATP concentration.  
A maximum rate of polymerization of 0.75 s-1 can be estimated from the rate of 
incorporation at higher AZATP concentrations. 
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Figure 4.16: Kinetics of incorporation of AZCTP by Pol γ 
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and then rapidly mixed with Mg+2 and various concentrations of AZCTP (10 (○), 
35 (●), 65 (□), 150 (■), and 300 µM ( )).  Each data set was fit to a double exponential.  
(B) The amplitude for fast phase for each reaction condition was plotted as a function of 
AZCTP concentration. A fit of the data to the hyperbola yields a Kd of 96 ± 6 µM. (C) 
The rate of the fast phase of each reaction was plotted against AZCTP concentration.  A 
maximum rate of polymerization of 2 s-1 can be estimated from the rate of incorporation 
at higher AZCTP concentrations. 
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Kinetics of incorporation of AZGTP by Pol γ 
AZGTP incorporation differed significantly from the other azide analogs 
examined both qualitatively and quantitatively.  The time dependent incorporation of 
AZGTP was fit to a single exponential (Figure 4.17A) and the amplitude of each reaction 
was plotted against AZGTP concentration (Figure 4.17B).  The dissociation constant 
from a hyperbolic fit of the amplitude was 50 ± 10 µM, about 3-fold tighter than AZTTP.  
The most interesting aspect of AZGTP incorporation by Pol γ was that the maximum rate 
of polymerization was nearly 200-fold slower than AZTTP incorporation (0.07 min-1 as 
estimated from the highest concentration of AZGTP used) (Figure 4.17C).  Furthermore, 
the rate increased linearly with concentration suggesting that the rate followed a simple 
one step binding model, kobs = kon[AZGTP] + koff.  An off rate of 0.028 ± 0.002 min-1 and 
an apparent second order rate constant of 7.5 ± 0.5 x 10-5 µM-1min-1, were obtained from 
the y-intercept and slope of the best fit line, respectively.  It should be noted that the 
values obtained by a linear fit may not be interpreted correctly because the amplitude 
dependence upon concentration skews the fitted rates.  The rate of an exponential is a 
reflection of the time it takes a reaction to reach equilibrium, therefore the low 
amplitudes at lower concentrations of AZGTP will tend to cause the fitted rates to 























































Figure 4.17: Kinetics of incorporation of AZGTP by Pol γ 
(A) Exonuclease-deficient holoenzyme (100 nM) was preincubated with 90 nM 25/45mer 
DNA and then rapidly mixed with Mg+2 and various concentrations of AZGTP (50 (○), 
100 (●), 200 (□), 325 (■), 450 ( ) and 600 µM ( )).  Each data set was fit to a single 
exponential.  (B) The amplitude for each reaction condition was plotted as a function of 
AZGTP concentration. The fit of the data to a hyperbola yields a Kd of 50 ± 10 µM. (C) 
The rate of each reaction was plotted against AZGTP concentration and was fit by linear 
regression to obtain a y-intercept (koff) of 0.028 ± 0.002 nM and a slope of (second order 




      kpol (s-1) b         Kd (µM)     Specificity (kpol/Kd)              Discriminationa
0.2 160 ± 40 1.3 ± 0.3 x 10-3 32,000 
0.75 800 ± 120 9.4 ± 1.4 x 10-4 44,000 





AZGTP 0.001 50 ± 10 2 ± 0.4 x 10-5 2,300,000 
a  Discrimination = (kpol/Kd)correct/(kpol/Kd)analog, where the values for dNTP incorporation in the presence of 
were taken from Ref (19) 
b  Values of rates of incorporation were estimated from the rate of incorporation at higher concentrations of 
AZNTP. 




The kinetics of incorporation of AZTTP are unusual, in that the rate stays 
approximately constant at various concentrations of nucleotide (~ 0.2 s-1) while the 
amplitude increases with concentration.  Similar results were found with each of the 3′-
azide analogs and are summarized above in Table 4.2.   
The amplitude of single-turnover polymerization reactions defines the amount of 
enzyme-DNA product complex that is rapidly formed during the first turnover.  The 
relationship between amplitude and concentration suggests that the phosphoryl transfer is 
reversibly linked to binding, such that, increasing concentrations of AZTTP drive the 
formation of product at equilibrium in the active site.   
Instead of fitting the rate dependence on concentration, a fit of the concentration 
dependence of the amplitude yields an apparent ground state dissociation constant of 160 
± 40 µM, the weakest binding of all nucleoside analogs examined in our laboratory to 
date.  The maximum rate of incorporation was simply taken to be 0.2 s-1, since there was 
little variation with concentration.   
The measured rate of pyrophosphate release of 0.007 min-1 suggests that the 
conformational change after phosphoryl transfer may be rate-limiting.  It is also possible 
that the release of pyrophosphate itself is rate-limiting; however it was shown that the 
DNA terminated with AZTMP dissociates more slowly than normal DNA.  Since there 
was no pyrophosphate present during that measurement, it appears that the 3′-azide group 
may interfere with the relaxation of the enzyme to an open conformation, thereby slowing 
the dissociation of PPi and DNA from the active site.  Furthermore, the inability to 
observe pyrophosphorolysis of DNA terminated with AZTMP by adding PPi from 
solution may suggest that the enzyme is largely in the closed conformation or that the rate 
 
of closure is very slow.  The most probable cause for the equilibrium observed for 
AZTTP incorporation is that after incorporation the enzyme remains in the closed 
conformation for an extended period of time with the active site residues aligned for 
catalysis with pyrophosphate remaining in position for the reaction, thus allowing the 
reaction to be reversible, and reach equilibrium on the time scale of a few seconds. 
Shown in Figure 4.18 are simulated data generated using KinTekSim computer 
simulation software using an initial collision (Kd) of 400 µM, a rate of 0.4 s-1 for the 
forward phosphoryl transfer reaction, a rate of 0.2 s-1 for the reverse (pyrophosphorolysis) 
reaction, and a rate of 0.007 min-1 for the conformational change following phosphoryl 
transfer.  The mechanism used for the simulation is shown in the following scheme 
(Figure 4.18 legend) along with the rates used for generating the data.  The mechanism 
was truncated in that the step representing the conformational change preceding 
phosphoryl transfer was omitted because it appears to be kinetically silent.  The Kd 
experimentally measured was about 160 µM and, according to this model, is the product 
of at least four steps in the reaction (on and off rates and forward and reverse phosphoryl 

































































Figure 4.18: Simulation of AZTTP incorporation by Pol γ 
(A) Shown are data points generated from KinTekSim computer simulation software 
using the mechanism and numbers in the scheme below for the incorporation of various 
concentrations of AZTTP (25 ( ), 75 ( ), 150 ( ), 250 ( ), 325 ( ), and 500 ( ) µM) 
under single turnover conditions.  Data were plotted as a function of time and fit to a 
single exponential equation.  (B) The single exponential amplitudes were plotted as a 
function of concentration and fit to a hyperbola to yield a theoretical Kd of 135 µM, 
which agrees well with the experimentally measured Kd of about 160 µM.  (C) The single 
exponential rates were plotted as a function of concentration to illustrate that they do not 
vary greatly with concentration.  The experimentally obtained data was plotted previously 








The incorporation of the other 3′-azide analogs revealed that, except for AZGTP, 
they also exhibit similar reaction kinetics, suggesting that an azide group on the 3′ carbon 
has a profound effect on the conformational change following phosphoryl transfer.  The 
results for AZGTP were somewhat different, in that the amplitude and rate varied with 
concentration and cannot be explained in detail at this time.  The incorporation of 
AZGTP was about 170-fold slower than AZTTP, possibly masking the equilibrium of 
phosphoryl transfer somewhat, due to the rate of incorporation being comparable to the 
rate of the conformational change following phosphoryl transfer. 
We are now confident that the calculation of the toxicity index for AZTTP is 
accurate as calculated from the apparent Kd obtained by fitting the single exponential 
amplitude of AZTTP incorporation (160 ± 40 µM).  AZTTP is the second least toxic 
analog (according to the toxicity index) we examined due, in large part, to the weak 
apparent binding compared to the other analogs.  PMPA had a Kd of 40.3 ± 5.7 µM (32), 
the second lowest binding affinity of the inhibitors inspected.  However, questions remain 
regarding the clinical toxicity that is observed for AZT, although minor compared to ddC, 
d4T and ddI.  Studies in vivo with AZTTP have shown it to cause ultrastructural changes 
in mitochondria (83;84), but other studies have shown that AZT causes bone marrow 
toxicity, in contrast to other nucleoside analogs.  Therefore AZT toxicity is thought to be 
due to inhibition of one or more of the chromosomal DNA polymerases (48).  In 
nonproliferating cells, nucleoside analogs, including AZT, have been documented to 
inhibit Pol γ specifically (48;85-88).  Recent studies with HepG2 cells have shown that 
AZT can reduce oxidative phosphorylation without reducing the amount of mtDNA (89), 
and that oxidative damage to mtDNA was increased in muscle and liver tissues of mice 
treated with AZT (90;91), suggesting that AZT causes mitochondrial dysfunction by 
some mechanism other than inhibition of mtDNA synthesis (92).  Such a large array of 
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reports has lead to confusion regarding AZT toxicity, but simply taken at face value our 




Chapter 5:  Exonuclease Removal of ddC and incorporation of 
Acyclovir-TP and dd2APyTP by Pol γ 
INTRODUCTION 
Incorporation of nucleoside analogs by the mitochondrial DNA polymerase γ has 
been implicated as the primary cause underlying many of the toxic side effects of these 
drugs in HIV therapy.  Recently, we have accomplished a detailed mechanistic analysis 
of the reactions governing nucleotide selectivity of the mitochondrial polymerase and its 
proofreading exonuclease.  The toxic side effects of nucleoside analogs are correlated 
with the kinetics of incorporation by Pol γ, varying over 6 orders of magnitude in the 
sequence zalcitabine (ddC) > didanosine (ddI metabolized to ddA) > stavudine (d4T) > 
lamivudine (3TC) > tenofovir (PMPA) > zidovudine (AZT) > abacavir (metabolized to 
carbovir, CBV) (32;60). Of the nucleoside analogs examined, ddCTP was the least 
effectively discriminated against by Pol γ with a discrimination of only 2.9, in that 
ddCTP was incorporated 70-fold more slowly, but bound 27-fold more tightly than the 
natural nucleotide, dCTP (93).  In addition, the rate of excision of ddC was reported to be 
too slow to measure, suggesting that ddC is effectively a suicide inhibitor of 
mitochondrial DNA synthesis (94).  In this chapter we reinvestigate this apparently 
anomalous result. 
Peripheral neuropathy is the primary dose-limiting adverse effect observed with 
the long term use of ddC and other nucleoside analogs (95;96).  Cell culture experiments 
that quantify the potencies of inhibition of mtDNA synthesis have shown ddC to cause 
almost complete depletion of mtDNA after 9-days of incubation at a concentration of 30 
µM, leading to a virtual knockout of cytochrome c oxidase II (COX II) expression (COX 
II is encoded by the mitochondrial genome) in human hepatoblastoma (HepG2) cells 
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(97).  Also, in a rabbit model of ddC-induced neuropathy, it has been shown that there 
were significant mitochondrial alterations in Schwann cells (98).  The inefficiency of 
excision of ddCMP from terminated DNA by Pol γ may contribute to the profound 
inhibition of mtDNA synthesis. 
In the case of the slow or nonexistent hydrolysis of chain terminators, 
comparisons between Pol γ and HIV-1 RT would be effectively reduced to comparisons 
between their respective abilities to discriminate correct from incorrect during 
incorporation, since RT lacks a proofreading mechanism (32).  An in-depth 
understanding of the mechanistic cause for the slow rate of removal is therefore of great 
interest in designing less toxic antiviral drugs. 
MATERIALS AND METHODS 
Nucleotides and oligonucleotides 
Acyclovir-TP was purchased from Moravek Biochemicals (Brea, CA), dd2APyTP 
was provided by Dr. Larry McLaughlin (Boston College, Chestnut Hill, MA), and 
unmodified dNTP's and ddCTP were purchased from Sigma Aldrich Corp. (St. Louis, 
MO).  Oligonucleotides were purchased from Integrated DNA Technologies (Coralville, 
IA). 
Pol γ expression and purification 
Overexpression and purification of recombinant human Pol γ were previously 
described (11;12). Holoenzyme was reconstituted at a 1:5 ratio of catalytic subunit to 
accessory subunit.  Unless stated otherwise, all kinetic studies were conducted using a 
wild type Pol γ, but in cases of incorporation reactions an exonuclease-deficient mutant 
(E200A) was used. 
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Preparation of DNA 
The 26mer primer sequence was 5′-GCCTCGCAGCCGTCCAACCAACTCAX-
3′, where the bold X signifies the position where either dC or ddC was placed.  The 
template sequence which was correctly base paired with the primer strand was 5′-
GGACGGCATTGGATCGACAGTGAGTTGGTTGGACGGCTGCGAGGC-3′.  The 
template sequence for the DNA containing eight different bases to create a frayed primer 
was 5′-GGACGGCATTGGATCGACAATATCAAGGTTGGACGGCTGCGAGGC-3′ 
Primer was 5′-32P-labeled using T4 polynucleotide kinase, according to the 
manufacturer’s instructions (Life Technologies, Gaithersburg, MD). The reaction was 
terminated by incubation at 95°C for 5 minutes, and excess nucleotide was removed 
using a Bio-Spin 6 column (BioRad, Hercules, CA).  Primer was annealed to 45-mer 
template by combining at an equimolar ratio, heating to 95 °C, and slowly cooling to 
room temperature.   
Polymerization and exonuclease reaction conditions 
For reactions too fast to measure by manual mixing and quenching, a quench-flow 
apparatus (RFQ-3) from KinTek Corp. (Austin, TX) was used.  Unless otherwise stated 
incorporation and exonuclease assays were performed at 37oC in buffer containing 50 
mM Tris-Cl, pH 7.5, 100 mM NaCl, 2.5 mM MgCl2.  For one experiment the reactions 
were performed in buffer containing 50 mM Tris-acetate pH 7.5, 100 mM potassium 
acetate, 2.5 mM MgCl2, and 0.1 mM EDTA.  The holoenzyme was reconstituted by 
incubating the two protein subunits for 5 min on ice in reaction buffer lacking 
magnesium. DNA was then added to the proteins, and the mixture was incubated for an 
additional 5 min on ice.  Incorporation reactions were initiated by the addition of 
nucleotide and magnesium in the same reaction buffer at 37 °C and then quenched with 
0.5 M EDTA. Alternatively, the excision reactions were initiated by the addition of 2.5 
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mM MgCl2.  All concentrations given are concentrations after mixing.  Products were 
separated on 15% denaturing polyacrylamide sequencing gels, imaged on a Molecular 
Dynamics Storm 860, and quantified using ImageQuaNT software (Amersham 
Biosciences, Uppsala, Sweden).   
Ground state dissociation constant and maximum rate of polymerization for nucleoside 
analog triphosphates 
Single nucleotide incorporation assays were performed with various 
concentrations of nucleoside analogs to examine the nucleotide concentration dependence 
of the incorporation rate.  Single-turnover conditions were employed where the 
concentration of enzyme was greater than the concentration of DNA. Specific reaction 
conditions are listed in each Figure legend.  A time course was performed for each 
concentration of nucleoside analog triphosphate.  To normalize data, the integrated 
amount of product (DNAn+1) was divided by the sum of the substrate and product (DNAn 
+ DNAn+1) and multiplied by the concentration of DNA used in the experiment.  The 
concentration of extended product DNA was plotted against time and fit to a single 
([product] = A1*e-k1t +C) or double ([product] = A1*e-k1t + A2*e-k2t + C), exponential 
equation (according to the Figure legends and results section).  The observed rates were 
then plotted against nucleoside analog triphosphate concentration, and the data were fit to 
a hyperbola (observed rate = kpol * [dNTP]/(Kd + [dNTP]) to obtain the Kd and the 
maximum rate of polymerization, kpol for the nucleoside analog triphosphates. 
RESULTS 
ddC removal from correctly paired or frayed DNA 
In our previous work on the toxicity of nucleoside analogs, we found that the rate 
for the exonuclease removal of ddC was too slow to measure under steady-state 
conditions (32).  We revisited this phenomenon by examining in greater detail the 
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kinetics of exonuclease removal of ddC.  With a defined primer and template of 26 and 
45 bases, respectively, we designed one duplex to be completely complementary in the 
double stranded region and one duplex, with 8 mismatches on the 3′-terminus of the 
primer.  The rationale for using frayed duplex stems from results obtained by Allison A. 
Johnson with Pol γ in our lab, where the rate of excision increased to a maximum of 
about 9 s-1 as the number of mismatches increased (0-7 mismatches) (27).  Therefore, it 
appeared that primer melting was a least partially rate-limiting in the excision of correctly 
paired DNA, but as the number of mismatches increased, the rate-limiting step was more 
likely to take place after strand transfer from the polymerase site to the exonuclease site.  
In addition to the rate increasing, the reaction became biphasic with the amplitude of the 
fast phase increasing as the number of mismatches increased, suggesting that a 
percentage of primer was positioned in the exonuclease site at the start of the reaction 
with mismatched DNA.   
Before examining the kinetics of ddC removal we measured the rate of removal of 
dC from both correctly paired DNA and frayed DNA.  Wild type holoenzyme was 
preincubated under single-turnover conditions with either correctly paired or frayed DNA 
and mixed with Mg+2 to start the reaction (Figure 5.1A).  The removal of correctly base 
paired dC was biphasic with rates of 0.86 ± 0.35 s-1 and 0.016 ± 0.004 s-1 and 
corresponding amplitudes of 21 ± 3 nM and 70 ± 3 nM, respectively.  We did not expect 
the reaction of correctly paired DNA to be biphasic, but the amplitude of the fast phase 
was only 30 percent of the amplitude of the slow phase.  The amplitude of the fast phase 
may represent the fraction of primer strand that was slightly frayed or present at the 
exonuclease site of Pol γ when the reaction was started.  The exonuclease reaction with 8 
base pair frayed DNA was also biphasic with rates of 1.6 ± 0.5 s-1 and 0.1 ± 0.07 s-1 and 
with amplitudes of 60 ± 10 nM and 25 ± 10 nM, respectively.  The rate of the fast phase 
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increased only slightly, but the amplitude was increased to 60 nM compared to the 
correctly paired DNA.  This is probably due to a larger percentage of the primer present 
at the exonuclease site when the reaction was started.  The rate of the slow phase for 
frayed DNA was an order of magnitude larger than for the correctly paired DNA, 
presumably because the rate of melting for correctly paired DNA was slower than that of 
frayed DNA. 
The reactions with ddC-terminated primers were dramatically different, in that 
they were much slower and removal only occurred at a single rate (Figure 5.1B).  The 
rate for the removal of ddC-terminated correctly paired DNA was 3 ± 0.4 x 10-4 s-1, 50-
fold slower than the slow phase of dC removal.  The removal of ddC from frayed DNA 
occurred at a rate of 4.4 ± 0.5 x 10-3 s-1, 15-fold faster than with correctly paired ddC-
terminated primer.  Both reactions went 100 percent to completion with slower rates than 
the rate of dissociation of DNA from the enzyme active site (0.02 s-1), suggesting that the 
DNA dissociates from the enzyme before removal occurs. 
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Figure 5.1:  Exonuclease removal of dC and ddC-terminated primers with or without 
frayed termini 
(A) Wild type holoenzyme (100 nM) was preincubated with 90 nM 26/45mer terminated 
with dC correctly base paired (○) or frayed at the 3′-terminus (8 mismatches) (●) and 
mixed with Mg+2 to start the reaction.  Concentration of substrate as a function of time 
was plotted and fit to a double exponential equation.  Both the correctly base paired and 
frayed DNA containing reactions were biphasic.  The correctly paired dC DNA was 
excised at rates of 0.86 ± 0.35 s-1 and 0.016 ± 0.004 s-1 with amplitudes of 21 ± 3 nM and 
70 ± 3 nM, respectively.  The frayed dC-terminated DNA was excised at rates of 1.6 ± 
0.5 s-1 and 0.1 ± 0.07 s-1 with amplitudes of 60 ± 10 nM and 25 ± 10 nM, respectively.  
(B) The same reaction conditions as in (A) were used, except the primer was terminated 
with ddC.  Substrate was plotted as a function of time and fit to a single exponential 
equation.  The reactions were not double exponentials as in (A), and were dramatically 
slower at a rate of 3 ± 0.4 x 10-4 s-1 for correctly paired ddC-terminated primer (○) and 
4.4 ± 0.5 x 10-3 s-1 for ddC-terminated frayed DNA (●).  Both had full amplitudes of 




Removal of ddC in the presence of dNTP 
In the mitochondria, all four nucleotides are present which could affect the rate of 
removal of ddC.  If ddC is incorporated, it is possible that the rate of excision be slowed 
by the presence of dNTP, because the next correct nucleotide could bind leading to a 
closed enzyme/DNA complex which is unable to catalyze the addition of the next 
nucleotide.  This could result in a slower rate of exonuclease removal because the 
enzyme remains in the closed conformation and the melting of the primer strand over into 
the exonuclease site would be inhibited.  In agreement, ddC removal with correctly 
paired DNA in the presence of 100 µM dNTP was slowed by almost four-fold to a rate of 
8.0 ± 0.7 x 10  s  (Figure 5.2).  However, the rate of removal of ddC with frayed DNA 




4.4 ± 0.5 x 10-3 s-1).  Apparently, the presence of the next correct nucleotide was 
insufficient to lead to a large enough percentage of closed enzyme/DNA complex to 
inhibit strand transfer. 
dC and ddC removal from correctly paired or frayed DNA in K+-acetate buffer 
Since K+ is the normal intracellular cation K+ instead of Na+; the effect K+ on the 
rate of excision of dC and ddC was inspected.  Similar to the previous reactions, wild 
type Pol γ holoenzyme was preincubated under single-turnover conditions with correctly 
paired or frayed DNA terminated with either dC or ddC and mixed with Mg+2 to start the 
reaction (Figure 5.3A-Figure 5.3B).  The removal of dC from both correctly paired and 
frayed DNA both occurred at single exponential rates of 0.011 ± 0.004 s-1 and 0.27 ± 0.03 
x 10-3 s-1, respectively.  These rates were marginally slower, in that they match up better 
with the slow phase of the reactions performed with Na+, but what may be more 
interesting is the lack of biphasic kinetics for either set of DNA.  This suggests that most 
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or all of the primer may be at the polymerase site when the reaction was started with 
correctly paired DNA, or in the case of frayed DNA all of the primer may have been at 
the exonuclease site or the rate of excision and strand transfer were comparable and were 
not resolved.  The rates of ddC removal for the correctly paired and frayed DNA were 
nearly identical to the reaction performed with Na+. 
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Figure 5.2:  Exonuclease removal of ddC in the presence of dNTP with or without frayed 
termini 
Wild type holoenzyme (100 nM) was preincubated with 90 nM 26/45mer terminated with 
ddC correctly base paired (○) or frayed at the 3′-terminus (8 mismatches) (●) and mixed 
with Mg+2 and 100 µM dNTP to start the reaction.  Concentration of substrate as a 
function of time was plotted and fit to a single exponential equation.  The correctly paired 
ddC-terminated DNA was excised at a rate of 8 ± 0.7 x 10-5 s-1.  The frayed ddC-
terminated DNA was excised at a rate of 6.3 ± 0.3 x 10-3 s-1 with amplitudes of about 90 
nM.  The reaction with correctly paired ddC-terminated DNA was assumed to go to 




































Figure 5.3:  Exonuclease removal of dC and ddC in K+-acetate buffer with or without 
frayed termini 
(A) Wild type holoenzyme (100 nM) was preincubated with 90 nM 26/45mer terminated 
with dC correctly base paired (○) or frayed at the 3′-terminus (8 mismatches) (●) and 
mixed with Mg+2 to start the reaction.  Concentration of substrate as a function of time 
was plotted and fit to a single exponential equation.  The correctly paired dC-terminated 
DNA was excised a rate of 0.011 ± 0.004 s-1.  Frayed dC-terminated DNA was excised at 
a rate of 0.27 ± 0.03 x 10-3 s-1.  (B) The same reaction conditions as in (A) were used 
except the primer was terminated with ddC.  The correctly paired ddC-terminated DNA 
was excised a rate of 3 ± 0.3 x 10-4 s-1.  The frayed ddC-terminated DNA was excised at a 




Incorporation of dd2APyTP 
dd2APyTP was synthesized in Larry W. McLaughlin's laboratory at Boston 
College where they obtained promising preliminary results for the efficient incorporation 
by HIV reverse transcriptase but not by mammalian polymerases.  The analog had two 
differences from the natural nucleoside, dC; one was a modification of the nucleobase 
residue to eliminate the O2-carbonyl, and the second was that it was a synthesized from 
2′,3′-dideoxyribose, so that is was a chain terminator (Figure 5.4A) (99).  A 25/45mer 
was designed to have a G corresponding to the 26th primer position and preincubated with 
exonuclease-deficient holoenzyme under single-turnover conditions and mixed with Mg+2 
and various concentrations of dd2APyTP to start the reaction (Figure 5.4B).  The rates 
from the single exponential fits were plotted against concentration and fit to a hyperbola 
to obtain a Kd of 105 ± 10 µM and a kpol of 0.004 ± 0.0002 s-1, for a specificity constant 
(kpol/Kd)of 3.8 ± 0.4 x 10-5 µM-1s-1.  Surprisingly, a discrimination (calculated as 
(kpol/Kd)dCTP/(kpol/Kd)dd2APyTP) against dd2APyTP of about 1.2 million is the greatest we 
have seen for the various nucleoside analogs examined (32;60).  Interestingly, the rate of 
removal, which was measured previously (99), was identical to the rate of removal of 
ddC, suggesting little to no role of the O2-carbonyl in the exonuclease removal of 
dd2APyMP. 
Incorporation of acyclovir-TP 
Previous studies with PMPA, an adenosine analog, (structure shown in Figure 
4.1) showed that even when an analog lacked the 3′ carbon (no ribose ring) it could still 
be incorporated by Pol γ, albeit with severely reduced rates.  Acyclovir (Zovirax) is an 
antiviral drug used to treat herpes infections of the skin, lip, and genitals; herpes zoster 
(shingles); and chickenpox. It can be administered as an ointment or orally.  Acyclovir, a 
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guanosine analog, also lacks the ribose ring; in fact, it has neither the 2′ nor the 3′ 
carbons.  Generally speaking the larger the modification to the ribose ring the lower the 
predicted toxicity is according to our toxicity index (32;60).   
A 25/45mer coding for G incorporation (26th primer position) was preincubated 
with exonuclease-deficient holoenzyme under single-turnover conditions and mixed with 
Mg+2 and various concentrations of acyclovir-TP to start the reaction (Figure 5.4B).  The 
rates from the single exponential fits were plotted against concentration and fit to a 
hyperbola to obtain a Kd of 1.6 ± 0.3 µM and a kpol of 0.31 ± 0.05 s-1, for a specificity 
constant of 0.19 ± 0.05 µM-1s-1.  The discrimination against acyclovir-TP of about 240 is 
surprisingly poor considering PMPA is discriminated against by a factor of 11,400.  This 
suggests that toxic side effects would result if concentrations of acyclovir-TP reach 






































Figure 5.4:  Incorporation of dd2APyTP 
(A) Shown is the structure and base pairing arrangement for dd2APyTP.  The analog 
lacks a carbonyl oxygen on the 2-carbon and also lacks a 3′-OH necessary for elongation 
making it a chain terminator (Figure from ref (99)).  (B) Exonuclease-deficient 
holoenzyme (100 nM) was preincubated with 90 nM 25/45mer DNA duplex (G in the 
template at the 26th position), and then rapidly mixed with Mg+2 and various 
concentrations of dd2APyTP (25 (○), 50 (●), 100 (□), 200 (■), 300 ( ), 400 ( ), 500 
( ), and 600 ( ) µM). Each data set was fit by non-linear regression to a single 
exponential equation to obtain the rate of incorporation.  (C) The single exponential rates 
were plotted as a function of dd2APyTP concentration. A fit of the data to a hyperbola 













































Figure 5.5:  Incorporation of acyclovir-TP 
(A) Shown is the structure of acyclovir-TP.  The 2′ and 3′ carbons are removed compared 
to dGTP.  The triphosphate is the active form of the drug.  (B) Exonuclease-deficient 
holoenzyme (100 nM) was preincubated with 90 nM 25/45mer DNA (C in the template at 
the 26th position) duplex, and then rapidly mixed with Mg+2 and various concentrations of 
acyclovir-TP (0.3 (○), 0.4 (●), 0.5 (□), 0.6 (■), 0.7 ( ), 0.8 ( ), 1( ), and 2 ( ) µM). 
Each data set was fit by non-linear regression to a single exponential equation to obtain 
the rate of incorporation.  (C) The single exponential rates were plotted as a function of 
acyclovir-TP concentration. A fit of the data to a hyperbola yields a Kd = 1.6 ± 0.3 µM 




The rate of exonuclease removal of ddC was more accurately measured than 
previously and was shown to be 3.0 ± 0.4 x 10-4 s-1  The rate was slowed by about 4-fold 
in the presence of dNTP, and is probably a more accurate representation of the 
physiological rate.  The rate increased 15-fold when frayed DNA was used.  This 
illustrates the effect of kinetic partitioning between the polymerase and the exonuclease 
site of the enzyme.  For instance, the rate of the slow phase of correctly paired dC 
removal was 0.016 ± 0.004 s-1 (50-fold faster than ddC removal), which most likely 
represents the rate of melting of primer strand and transfer into the exonuclease site.  
Although melting may not be rate limiting for ddC removal, the observed excision rate 
increased 15-fold when using frayed DNA.  It is possible that there is an equilibrium 
between the exonuclease and polymerase sites with the majority of the correctly paired 
DNA at the polymerase site.  Furthermore, the fact that the addition of the next correct 
dNTP slows the rate of removal about 4-fold seems to agree well, because the closed 
form of the enzyme would tend to slow melting and transfer of the primer to the 
exonuclease site.  In any case, the rate of ddC removal is the slowest rate of removal of 
the nucleoside analogs we have examined, and is the most toxic of the nucleoside analogs 
approved for use as anti-HIV drugs. 
The design of dd2APyTP in Dr. Larry McLaughlin's laboratory was based on 
recent work suggesting that mammalian polymerases make minor grove contacts with 
functional groups of the base residues of both the primer and templates and a change in 
the geometric shape of the base could lead to lower specificity of a nucleoside analog 
(99).  The analogs approved to date have ribose ring modifications, and essentially native 
bases.  From the kinetics of incorporation a discrimination against dd2APyTP of 1.2 
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million by Pol γ suggests that at least from the perspective of toxicity, could be a 
promising new drug lead.  However, the rate of removal was identical to that of ddC.  
The contribution of the rate of removal for nucleoside analog toxicity is generally 
unknown, but after incorporation the polymerase will almost definitely dissociate from 
the chain terminated DNA.  This is potentially a problem if the concentration Pol γ is 
relatively low in the mitochondria, because the slow rebinding of the polymerase would 
decrease the rate of excision further. 
The incorporation of acyclovir was examined to inspect the effects of partially 
removing the ribose ring compared to the natural nucleotide, dGTP.  In contrast to 
PMPA, the discrimination against acyclovir was significantly reduced (11,700 versus 
240, respectively).  This suggests that the high discrimination against PMPA is a result of 
the presence of the 2′ methyl group, the lack of a methylene group between the ribose 
oxygen and the nearest phosphate, or the effect is base specific (PMPA is an A analog 
and acyclovir is a G analog) or a combination of all three. 
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Chapter 6:  Replication of Oxidatively Damaged DNA by Pol γ 
INTRODUCTION 
While several theories exist regarding the underlying molecular mechanisms that 
cause aging in mammals, the mitochondrial theory of aging recently has gained credence 
(61;100).  According to the mitochondrial theory of aging, electrons from the electron 
transport chain, most likely from complex I, are able to reduce molecular oxygen to form 
superoxide anion radicals (O2-) during aerobic respiration.  These reactive radicals go on 
to produce other reactive oxygen species (ROS) (61).  ROS can be generated at a few 
cellular sites, but in healthy tissues, the majority are from metabolism.  For that reason, 
they are always present at normal cellular activity levels.  ROS attack a variety of 
different cellular macromolecules, including proteins, lipids and DNA.  However, 
damage to mtDNA has been implicated as the most important in regard to aging, 
especially in postmitotic cells, such as neurons (70), in part because the damage caused at 
other sites is essentially reversible by virtue of the information contained within DNA.  A 
cycle is created in the mitochondria under this continued state of oxidative stress leading 
to further damage to electron transport chain components, and ultimately causing an 
energy decline, carcinogenesis, and many age-related diseases (101).   
One of the most common products of oxidative DNA damage is 8-hydroxy-2′-
deoxyguanosine (8-oxodG), which is reported to be highly mutagenic and is commonly 
used as biomarker for oxidative stress.  Basal levels of 8-oxodG in mtDNA between 
different species correlate negatively with longevity in many mammals and birds, which 
is not the case with nuclear DNA (nDNA) (71).  Moreover, due to the proximity of 
mtDNA to the electron transport chain, the levels of oxidative damage are significantly 
higher in all tissues of mammals and birds examined than in the nucleus (72).  It is now 
 
established that caloric restriction increases the life span of rodents and is correlated with 
less mtDNA damage and age (102). 
While much is known regarding the DNA repair pathways in the nucleus, 
comparatively little is known about the mitochondria.  The repair of 8-oxodG is carried 
out by the base excision repair (BER) pathway, and its efficiency is evaluated by 8-
oxodG glycosylase activity which increases over the life span of rodents but does not 
seem to stop the accumulation of 8-oxodG during aging (103;104).   
The concern surrounding 8-oxodG stems from its mutagenic coding potential 
when copied by an assortment of mammalian and prokaryotic polymerases (73-75).  For 
all studies done with DNA polymerases, dC and dA were inserted across from 8-oxodG 
with comparable but varying efficiencies which potentially results in a G to T 
transversion mutation.  The molecular mechanism for the lack of specificity afforded by 
8-oxodG is thought to be due to its ability to form either a normal Watson-Crick 
hydrogen bonding arrangement with dCMP or a Hoogsteen base pair with dAMP by 
flipping to the syn conformation (76;77). 
 
Arguably, the most important polymerase in regard to the replication of 
oxidatively damaged DNA is the human mitochondrial polymerase γ (Pol γ), which is 
responsible for the propagation and maintenance of the mitochondrial genome.  Pertinent 




knock-in that expressed a proofreading deficient version of Pol γ.  The mice prematurely 
developed numerous signs of aging, presumably as a result of the reduction in the fidelity 
of replication of the mitochondrial genome (31).  
We have examined in detail the kinetic parameters governing the fidelity of 
oxidatively damaged DNA replication by using a recombinant reconstituted human Pol γ 
and transient-state kinetic techniques.  Due to growing evidence for the possibility and 
significance of damaged free nucleotides incorporated during the replication of DNA, we 
also investigated the kinetics of 8-oxodGTP incorporation (75;105-107). 
MATERIALS AND METHODS 
Nucleotides and oligonucleotides 
8-oxodGTP was purchased from TriLink BioTechnologies (San Diego, CA), and 
unmodified dNTP were purchased from Sigma-Aldrich (St. Louis, MO).  
Oligonucleotides containing 8-oxodG (except for the primer terminated with 8-oxodG, 
which was enzymatically synthesized in our lab) were purchased from The Midland 
Certified Reagent Company (Midland, TX), and all other (unmodified) oligonucleotides 
were purchased from Integrated DNA Technologies (Coralville, IA). 
Pol γ expression and purification 
Overexpression and purification of recombinant human Pol γ were previously 
described (11;12). Holoenzyme was reconstituted at a 1:5 ratio of catalytic subunit to 
accessory subunit.  Unless stated otherwise all kinetic studies were conducted using an 
exonuclease-deficient mutant (E200A). 
Preparation of DNA 
The 25mer primer sequence was 5′-GCCTCGCAGCCGTCCAACCAACTCA-3′, 




the bold X in the template was modified according to the particular experiment 
performed (any modifications to the primer and template base sequences are detailed in 
the results section).  Primer was 5′-32P-labeled using T4 polynucleotide kinase, according 
to the manufacturer’s instructions (Invitrogen, Carlsbad, California). The reaction was 
terminated by incubation at 95°C for 5 minutes, and excess nucleotide was removed 
using a Bio-Spin 6 column (BioRad, Hercules, CA).  The primer was annealed to 45mer 
template by combining at an equimolar ratio, heating to 95°C, and slowly cooling to 
room temperature.  Primers containing 3′-terminal 8-oxodG were enzymatically 
synthesized because they could not be chemically synthesized.  A polymerase reaction 
was performed using 1 µM Pol γ, 100 µM duplex DNA (containing dC as the template 
base opposite 26th primer position), and 150 µM 8-oxodG in standard reaction buffer (50 
mM Tris-Cl, pH 7.5, 100 mM NaCl, 2.5 mM MgCl2).  The reaction mixture was 
incubated at 37°C for 30 min, and then the product was gel-purified to obtain the 8-
oxodG-terminated primer. Primer was labeled with 32P on the 5′-end, and DNA duplex 
was annealed as described above. 
Polymerization and exonuclease reaction conditions 
For reactions too fast to measure by manual mixing and quenching, a quench-flow 
apparatus (RFQ-3) from KinTek Corporation (Austin, TX) was used.  All incorporation 
assays were performed at 37oC in buffer containing 50 mM Tris-Cl, pH 7.5, 100 mM 
NaCl, and 2.5 mM MgCl2.  The holoenzyme was reconstituted by incubating the two 
protein subunits for 5 min on ice in reaction buffer lacking magnesium. DNA was then 
added to the proteins, and the mixture was incubated for an additional 5 min on ice.  
Incorporation reactions were initiated by the addition of nucleotide and magnesium in the 
same reaction buffer at 37°C and then quenched with 0.5 M EDTA. Alternatively, the 
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excision reactions were initiated by the addition of 2.5 mM MgCl2.  All concentrations 
given are concentrations after mixing.  Products were separated on 15% denaturing 
polyacrylamide sequencing gels, imaged on a Molecular Dynamics Storm 860 Imager, 
and quantified using ImageQuaNT software (Amersham Biosciences, Uppsala, Sweden).   
Ground-state dissociation constant and maximum rate of polymerization for dNTP or 
8-oxodGTP 
Single nucleotide incorporation assays were performed with various 
concentrations of dNTP or 8-oxodGTP to examine the nucleotide concentration 
dependence of incorporation rate or amplitude.  Single-turnover conditions were 
employed where the concentration of enzyme was greater than the concentration of DNA. 
Specific reaction conditions are listed in each Figure legend.  A time course was 
performed for each concentration of dNTP.  To normalize data, the integrated amount of 
product (DNAn+1) was divided by the sum of the substrate and product (DNAn + DNAn+1) 
and multiplied by the concentration of DNA used in the experiment.  The concentration 
of extended DNA product was plotted against time and fit to a single ([product] = A1*e-k1t 
+C) or double ([product] = A1*e-k1t + A2*e-k2t + C) exponential equation (as stated in the 
Figure legends and results section).  The observed rates, and in one case, amplitudes were 
plotted against dNTP concentration, and the data were fit to a hyperbola (observed rate 
(or amplitude) = kpol (or Amax) * [dNTP]/(Kd + [dNTP]) to obtain the Kd and the 
maximum rate of polymerization, kpol or maximum amplitude (Amax), for each dNTP or 
8-oxodGTP. 
Kd for DNA binding 
A fixed concentration of enzyme was combined with increasing concentrations of 
DNA, allowed to equilibrate for 20 min on ice, and then reacted with an equal volume of 
nucleotide at 37°C.  Reactions were quenched after 0.3 s by the addition of 0.3 M EDTA. 
 
Final reaction conditions were 50 nM catalytic subunit, 500 nM accessory subunit, 300 
µM dGTP, 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2.5 mM MgCl2, and a range of 
DNA concentrations. The amount of DNA product was plotted as a function of substrate 






where Eo and D represent enzyme and DNA concentrations, respectively. 
 
RESULTS 
Incorporation of dATP prior to template 8-oxodG 
Single-turnover conditions were employed, in that the enzyme concentration was 
in excess of DNA concentration.  In order to understand in detail how Pol γ replicates 
DNA with oxidative damage, we designed a complementary primer and template 
combination of 24 and 45 bases, respectively.  At the 25th position of the template is a dT 
followed by an 8-oxodG at the 26th, so that with a 24mer primer a correct single 
nucleotide incorporation reaction could be performed using dATP to inspect 
incorporation just prior to 8-oxodG. 
 
 
Exonuclease-deficient Pol γ holoenzyme was preincubated with the 24/45mer (8-
oxodG) and rapidly mixed with increasing concentrations of dATP in a quench-flow 
apparatus, and at the specified times, quenched with 0.5 M EDTA.  The time dependent 




The single exponential rate for each reaction was plotted versus dATP concentration and 
fit to a hyperbola to obtain a ground-state dissociation constant (Kd) of 1.3 ± 0.2 µM and 
a maximum rate of polymerization (kpol) of 53 ± 5 s-1 (Figure 6.1B).  The specificity 
constant (kpol/Kd) of 40 ± 7 µM-1s-1 is close to that of dATP incorporation onto 
undamaged DNA of 57 ± 6 µM-1s-1 (19).  Therefore, the presence of 8-oxodG in the next 
template position does not alter the kinetics of incorporation.  
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Figure 6.1:  Incorporation of dATP prior to template 8-oxodG  
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 24/45mer 
((T(8-oxodG)AC), the bold T signifies the position of incorporation) DNA duplex and 
then rapidly mixed with Mg+2 and various concentrations of dATP (0.6 (○), 1 (●), 3 (□), 
6 (■), 10 ( ), and 25 ( ) µM). Each data set was fit by non-linear regression to a single 
exponential equation to obtain the rate of incorporation.  (B) the single exponential rates 
were plotted as a function of dATP concentration. A fit of the data to a hyperbola yields a 
Kd = 1.3 ± 0.2 µM and a kpol = 53 ± 5 s-1. 
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Incorporation of correct and incorrect base pairs onto 8-oxodG 
To inspect the incorporation of the four dNTP directly onto 8-oxodG, we 
designed a primer and template combination of 25 and 45 bases, respectively, with 8-
oxodG at the 26th position in the template. 
 
Exonuclease-deficient Pol γ holoenzyme was preincubated with the 25/45mer (8-
oxodG) and rapidly mixed with increasing concentrations of each dNTP (separate 
experiments were performed for each dNTP) in a quench-flow apparatus, and at the 
specified times, quenched with 0.5 M EDTA.  The time dependent formation of 26mer 
was fit to a single exponential equation and plotted in Figures 6.2-6.5A.  The single 
exponential rate for each reaction was plotted versus dNTP concentration and fit to a 
hyperbola to obtain the values for each Kd and kpol (Figures 6.2-6.5B).  The results are 




      kpol (s-1)            Kd (µM)        Specificity (kpol/Kd) 
10 ± 0.8 100 ± 13 0.100± 0.001 
3.4 ± 0.5 300 ± 70 0.011 ± 0.003 





dTTP 0.0061 ± 0.0005 110 ± 20 0.000055 ± 0.000002 
Table 6.1:  Summarized results for the incorporation of correct and incorrect nucleotides 
onto 8-oxodG 
The ground-state binding affinities and the rates of incorporation of each dNTP 
were reduced from that seen for unmodified dG in the template.  The specificities of the 
incorporation of the four nucleotides onto 8-oxodG reveal that Pol γ prefers dCTP only 9-
fold more than dATP when polymerizing over oxidatively damaged DNA.  dGTP and 
dTTP are poor as substrates in comparison to dCTP with specificity constants nearly 800 
and 2000-fold less, respectively.  Accordingly, 8-oxodG will be highly mutagenic with an 
error frequency of 1/10.  
Exonuclease removal of dCMP and dAMP paired with 8-oxodG 
To inspect the likelihood that dC and dA are stably incorporated onto 8-oxodG we 
designed two primer and template combinations (26/45mer) where at the 26th position 
was either a correct dC:8-oxodG base pair or an incorrect dA:8-oxodG base pair and 







 Wild-type Pol γ holoenzyme was preincubated with DNA under single-turnover 
conditions and mixed with Mg+2 to start the reaction.  The concentration of substrate 
26mer was plotted as a function of time and fit to a double exponential equation (Figure 
6.2C is removal of dC, and Figure 6.3C is removal of dA).  The removal of both dC and 
dA paired with 8-oxodG were biphasic with fast-phase rates of 0.08 ± 0.01 s-1 and 0.26 ± 
0.02 s-1, respectively.  The amplitude of the fast-phase of each removal reaction was 
about 60 nM which is the amount of Pol γ/DNA complex present at equilibrium (under 
our single-turnover conditions).  Therefore, the rate of removal for the slow phase of the 
reaction will be ignored because it is a function of the rate of DNA binding. 
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Figure 6.2:  Incorporation of dCTP onto a template 8-oxodG 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
25/45mer((T(8-oxodG)AC), the bold (8-oxodG) signifies the position of incorporation) 
DNA duplex and then rapidly mixed with Mg+2 and various concentrations of dCTP (0.6 
( ), 1 ( ), 5 (■), 10 (□), 40 (●), and 100 (○) µM). Each data set was fit by non-linear 
regression to a single exponential equation to obtain the rate of incorporation.  (B) The 
single exponential rates were plotted as a function of dCTP concentration. A fit of the 
data to a hyperbola yields a Kd = 100 ± 13 µM and a kpol = 10 ± 0.8 s-1.  (C) Shown is the 
excision of C, base-paired with 8-oxodG (template).  100 nM wild-type holoenzyme was 
preincubated with 90 nM 26C/45mer((T(8-oxodG)AC), the bold signifies bases that are 
directly across from one another) DNA duplex and mixed with Mg+2 to start the reaction.  
Concentration of substrate was plotted as a function of time and fit to a double 
exponential equation to obtain the rate of excision.  The reaction was biphasic with rates 



















































Figure 6.3:  Incorporation of dATP onto a template 8-oxodG 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
25/45mer((T(8-oxodG)AC), the bold (8-oxodG) signifies the position of incorporation) 
DNA duplex and then rapidly mixed with Mg+2 and various concentrations of dATP (2 
( ), 10 ( ), 40 (■), 100 (□), 250 (●), and 500 (○) µM). Each data set was fit by non-
linear regression to a single exponential equation to obtain the rate of incorporation.  (B) 
The single exponential rates were plotted as a function of dATP concentration. A fit of 
the data to a hyperbola yields a Kd = 300 ± 70 µM and a kpol = 3.4 ± 0.5 s-1.  (C) Shown is 
the excision of A, base-paired with 8-oxodG (template).  100 nM wild-type holoenzyme 
was preincubated with 90 nM 26A/45mer((T(8-oxodG)AC), the bold signifies bases that 
are directly across from one another) DNA duplex and mixed with Mg+2 to start the 
reaction.  Concentration of substrate was plotted as a function of time and fit to a double 
exponential equation to obtain the rate of excision.  The reaction was biphasic with rates 





























Figure 6.4:  Incorporation of dGTP onto a template 8-oxodG  
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
25/45mer((T(8-oxodG)AC), the bold (8-oxodG) signifies the position of incorporation) 
DNA duplex and then rapidly mixed with Mg+2 and various concentrations of dGTP (5 
( ), 25 ( ), 50 (■), 100 (□), 250 (●), and 500 (○) µM). Each data set was fit by non-
linear regression to a single exponential equation to obtain the rate of incorporation.  (B) 
The single exponential rates were plotted as a function of dGTP concentration. A fit of 































Figure 6.5:  Incorporation of dTTP onto a template 8-oxodG  
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
25/45mer((T(8-oxodG)AC); the bold (8-oxodG) signifies the position of incorporation) 
DNA duplex and then rapidly mixed with Mg+2 and various concentrations of dTTP (5 
( ), 25 ( ), 50 (■), 100 (□), 250 (●), and 500 (○) µM).  Each data set was fit by non-
linear regression to a single exponential equation to obtain the rate of incorporation.  (B) 
The single exponential rates were plotted as a function of dTTP concentration. A fit of 
the data to a hyperbola yields a Kd = 110 ± 20 µM and a kpol = 0.0061 ± 0.0005 s-1. 
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 Incorporation beyond correctly and incorrectly paired 8-oxodG 
In order to assess the ability for Pol γ to replicate oxidatively damaged DNA, it is 
important to inspect DNA synthesis past the site of damage as well.  This was 
accomplished by designing two primer and template combinations of 26 and 45 bases, 
respectively, starting synthesis at either a correct dC:8-oxodG or an incorrect dA:8-




Incorporation of dTTP by Pol γ was slightly more efficient at burying a dC:8-
oxodG base pair than a dA:8-oxodG mispair, with a Kd of 4.4 ± 1.0 µM and a kpol of 19 ± 
3 s-1 for the correct base pair (Figure 6.6) compared to a Kd of 10 ± 1 µM and kpol of 13 ± 
0.7 s-1 (Figure 6.7) for the mismatch.  The specificity was about 4-fold greater following 
the correct base pair, but both were efficiently incorporated beyond.  For reference, the 
normal incorporation of dTTP onto undamaged DNA by Pol γ occurs with a Kd of 0.6 
µM at a kpol of 25 s-1, illustrating that the efficiency was not altered dramatically.  
Furthermore, the rate of incorporation of dTTP was much faster than the rate of removal 
of either dC (0.08 s-1) or dA (0.26 s-1) base-paired with 8-oxodG.  Combining these 
results we calculate a 98 percent probability that a dA:8-oxodG mispair will be buried 

































































Figure 6.6:  Incorporation of dTTP beyond a dC:8-oxodG base pair 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
26C/45mer((T(8-oxodG)AC), the bold A signifies the position of incorporation) DNA 
duplex and then rapidly mixed with Mg+2 and various concentrations of dTTP (0.6 (○), 1 
(●), 3 (□), 10 (■), and 25 ( ) µM).  Each data set was fit by non-linear regression to a 
single exponential equation to obtain the rate of incorporation.  (B) The single 
exponential rates were plotted as a function of dTTP concentration.  A fit of the data to a 
hyperbola yields a Kd = 4.4 ± 1.0 µM and a kpol = 19 ± 3 s-1.  (C) Shown is the excision of 
T (T buries a C:8-oxodG (template) base pair).  100 nM wild-type holoenzyme was 
preincubated with 90 nM 27CT/45mer((T(8-oxodG)AC), the bold signifies bases that are 
directly across from one another) DNA duplex and mixed with Mg+2 to start the reaction.  
Concentration of substrate was plotted as a function of time and fit to a double 
exponential equation to obtain the rate of excision.  The reaction was biphasic with rates 























































Figure 6.7:  Incorporation of dTTP beyond a dA:8-oxodG base pair 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
26A/45mer((T(8-oxodG)AC), the bold A signifies the position of incorporation) DNA 
duplex and then rapidly mixed with Mg+2 and various concentrations of dTTP (1 (○), 5 
(●), 25 (□), 100 (■), 200 ( ), and 300 (▲) µM).  Each data set was fit by non-linear 
regression to a single exponential equation to obtain the rate of incorporation.  (B) The 
single exponential rates were plotted as a function of dTTP concentration. A fit of the 
data to a hyperbola yields a Kd = 10 ± 1 µM and kpol = 13 ± 0.7 s-1.  (C) Shown is the 
excision of T (T buries an A:8-oxodG (template) base pair).  100 nM wild-type 
holoenzyme was preincubated with 90 nM 27AT/45mer((T(8-oxodG)AC), the bold 
signifies bases that are directly across from one another) DNA duplex and mixed with 
Mg+2 to start the reaction.  Concentration of substrate was plotted as a function of time 
and fit to a double exponential equation to obtain the rate of excision.  The reaction was 
biphasic with rates of 0.26 ± 0.01 s-1 and 0.043 ± 0.003 s-1 and amplitudes of 65 ± 1 nM 
and 22 ± 1 nM, respectively. 
 
Removal of dT burying a correct or incorrect base pair with 8-oxodG 
To have an accurate idea of the probability that a mutation occurs during 
replication of oxidatively damaged DNA, it was necessary to inspect the rate of removal 
of a correct base pair following either a correct dC:8-oxodG or an incorrect dA:8-oxodG 
base pair.  Two primer and template combinations were designed where at the 26th 
position was either a correct dC:8-oxodG base pair or an incorrect dA:8-oxodG base pair 
and following that in the 27th position was a dT:dA base pair. 
 
 Removal of dT with both primer/template combinations was biphasic with fast-
phase rates of 0.16 ± 0.01 s-1 and 0.26 ± 0.01 s-1, respectively (Figure 6.6C is with dC:8-
oxodG, and Figure 6.7C is with dA:8-oxodG).  The amplitude of the fast phase of each 
removal reaction was, again, about 60 nM, which is the amount of Pol γ/DNA complex 
present at equilibrium (under our single-turnover conditions).  Therefore, the rate of 
removal for the slow phase of the reaction will be ignored.   
The ability of Pol γ to bury correctly and incorrectly base paired 8-oxodG 
Continuing the single-step kinetic analysis of oxidatively damaged DNA 
polymerization by Pol γ, we designed an experiment that would assay for the ability of 
Pol γ to bury either a correct dC:8-oxodG (26th position) base pair followed by a T:A 
base pair (27th position) or an incorrect dA:8-oxodG (26th position) base pair followed by 





Pol γ is actually 3-fold more efficient at copying DNA with the mispair (Figures 
6.8 and 6.9) at this step in polymerization.  This was evidenced by a Kd of 7.9 ± 0.3 µM 
and a kpol of 20.8 ± 0.6 s-1 for dGTP incorporation to bury a correct dC:8-oxodG base pair 
compared to a Kd of 3.2 ± 0.1 µM and a kpol of 27.7 ± 0.5 s-1 for dGTP incorporation to 
bury an incorrect dA:8-oxodG base pair.  Moreover, the amplitude of incorporation is 
about 10-15 nM higher for the reaction done with the mismatch, suggesting the enzyme 
binds tighter to the DNA with a mispair because the amplitude is a measure of the 
amount of productively-bound enzyme/DNA complex. 
Dissociation constant for oxidatively damaged DNA 
From the previous experiment it was discovered that the amplitude was lower 
than expected for dGTP incorporation onto the correctly base-paired 8-oxodG DNA 
primer/template combination.  Therefore, an active site titration was performed in order 
to determine the dissociation constant for DNA binding.  Exonuclease-deficient 
holoenzyme was preincubated with increasing concentrations of DNA and rapidly mixed 
with dGTP and Mg+2 to start the reaction.  A time point of 0.3 seconds was taken for each 
DNA concentration because at a saturating concentration of dGTP, product formation 
was expected to be to full amplitude.  Amplitude was plotted against DNA concentration 
and fit to the quadratic equation to obtain a Kd of 38 ± 12 nM (Figure 6.10).  The 
quadratic equation was used to calculate a concentration of 51 ± 5 nM enzyme/DNA 
complex at equilibrium for the conditions used in the single-turnover experiment.  The Kd 












































Figure 6.8:  Incorporation of dGTP onto 27CT/45(8-oxodG)AC 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
27CT/45mer((T(8-oxodG)AC), the bold C signifies the position of incorporation) DNA 
duplex and then rapidly mixed with Mg+2 and various concentrations of dGTP (0.6 (○), 1 
(●), 3 (□), 6 (■), 10 ( ), and 25 (▲) µM).  Each data set was fit by non-linear regression 
to a single exponential equation to obtain the rate of incorporation.  (B) The single 
exponential rates were plotted as a function of dGTP concentration. A fit of the data to a 
































Figure 6.9:  Incorporation of dGTP onto 27AT/45(8-oxodG)AC  
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 
27AT/45mer((T(8-oxodG)AC), the bold C signifies the position of incorporation) DNA 
duplex and then rapidly mixed with Mg+2 and various concentrations of dGTP (0.6 (○), 1 
(●), 3 (□), 6 (■), 10 ( ), and 25 (▲) µM).  Each data set was fit by non-linear regression 
to a single exponential equation to obtain the rate of incorporation.  (B) The single 
exponential rates were plotted as a function of dGTP concentration. A fit of the data to a 





















Figure 6.10:  Active site titration of Pol γ with 27CT/45(8-oxodG)AC 
Exonuclease-deficient holoenzyme (50 nM) was preincubated with increasing 
concentrations of 27CT/45mer((T(8-oxodG)AC), the bold C signifies the position of 
incorporation) DNA duplex and then rapidly mixed with Mg+2 and 200 µM dGTP.  After 
0.3 seconds, the reaction was quenched with 0.5 M.EDTA.  The amount of product 
(amplitude) was plotted against DNA concentration and fit to the quadratic equation to 
yield a Kd = 38 ± 12 nM for DNA binding. 
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Processive polymerization assay for replication of oxidatively damaged DNA 
To assess the extent to which Pol γ can replicate full-length product with an 
oxidative lesion in the template in a single binding event we performed a processive 
DNA polymerization assay in the presence of a DNA trap.  This was accomplished by 
using two primer and template combinations of 26 and 45 bases, respectively, starting 
synthesis at either a correct dC:8-oxodG or an incorrect dA:8-oxodG base pair and 




Exonuclease-deficient Pol γ holoenzyme was preincubated with 26/45mer DNA 
under single-turnover conditions and rapidly mixed with Mg+2, 100 µM dNTP, and a 20-
fold excess unlabeled DNA trap.  The presence of the trap ensures that the full-length 
product observed is synthesized from a single enzyme molecule in a single binding event.  
Full-length product (45mer) was plotted as a function of time (Figure 6.11) and shows 
that the concentration of the resulting product agrees well with the results from the single 
nucleotide incorporation reactions.  Interestingly, the amount of product obtained in the 
reaction starting with an dA:8-oxodG mismatch was significantly higher than the reaction 


















Figure 6.11:  Processive polymerization assay with 8-oxodG in the template 
100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 26C/45mer((8-
oxodG), the bold signifies starting base pair position in the substrate DNA duplex) (●) or 
26A/45mer((T(8-oxodG)AC) (○) DNA duplex and then rapidly mixed with Mg+2, 100 
µM dNTP, and an unlabeled 25/45mer DNA trap  (20-fold excess).  The concentration of 
full-length product was plotted as a function of time, showing that the reaction that 






Free dGTP has been shown to be even more susceptible to oxidation than dG in 
double-stranded DNA (106), which is of importance in the oxidative environment of the 
mitochondria.  Therefore, we investigated the possibility that the mutagenic 8-oxodG 
accumulates in the mitochondrial DNA as a result of incorporation of 8-oxodGTP by Pol 
γ.  Measurement of the kinetic parameters governing incorporation of 8-oxodGTP was 
carried out using an undamaged DNA primer and template of 25 and 45 bases (coding for 
G), respectively.  Exonuclease-deficient holoenzyme was preincubated with DNA and 
rapidly mixed with increasing concentrations of 8-oxodGTP.  Product formation as a 
function of time was plotted and fit to a double exponential equation (Figure 6.12A).  
There appears to be two dependencies occurring as a function of concentration of 8-
oxodGTP, amplitude of the fast phase (Figure 6.12B), and rate of the slow phase (Figure 
6.12C).  The amplitude of the fast phase was fit to a hyperbola to obtain a Kd of 200 ± 30 
µM while a fit of the slow phase rates revealed a Kd of 83 ± 7 µM and a kpol = 0.4 ± 0.02 
s-1.  The rate of the fast phase was relatively constant at about 2 s-1 and is reminiscent of 
data obtained with the 3' azide analogs (Chapter 4).  An estimate of the specificity 
constant was obtained by using the Kd based on the amplitude dependence and the kpol for 
the fast phase of the reaction and is equal to 0.01 ± 0.0015 µM-1s-1.  See "Discussion" for 
a more detailed analysis of this data.  Additional data regarding the incorporation of 8-
oxodGTP collected by David M. Thal in our laboratory showed that the incorporation to 
form a mismatch with dA has a Kd of 2.4 ± 0.8 µM and a kpol of 0.50 ±0.09 s-1 (data not 
shown) revealing its mutagenic potential even upon incorporation.  The specificity 
constant is 21-fold greater than for the formation of the "correct" base pair (8-oxodG:dC). 
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Figure: 6.12:  Incorporation of 8-oxodGTP onto a template dC by Pol γ  
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 25/45mer 
(G incorporation) DNA duplex and then rapidly mixed with Mg+2 and various 
concentrations of 8-oxodGTP (10 (▲), 25 ( ), 50 (■), 100 (□), 200 (●), and 400 (○) 
µM).  Each data set was fit by non-linear regression to a double exponential equation to 
obtain the rate and amplitude of incorporation.  (B) The single exponential amplitudes 
were plotted as a function of 8-oxodGTP concentration. A fit of the data to a hyperbola 
yields a Kd = 200 ± 30 µM and an Amax (maximum amplitude) = 62 ± 4 nM.  (C) The rate 
from the slow phase of each reaction was plotted as a function of 8-oxodGTP 




Also shown is the amplitude of the slow phase as a function of concentration with the y-
axis scale on the right side of the graph (○).  (D) The rate from the fast phase of each 




Exonuclease removal of 8-oxodGMP from the 3′ terminus of the primer 
To assess the probability that 8-oxodG is stably maintained in the mitochondrial 
genome once incorporated we examined the rate of excision using wild-type Pol γ and a 
26/45mer (the primer was enzymatically terminated with 8-oxodG and correctly paired 
with dC).  Plotted in Figure 6.13 is the concentration of substrate as a function of time 
with a fit to a single exponential equation.  Interestingly, a rate of exonuclease removal of 
0.075 ± 0.002 s-1 for the "correct" base pair was about 9-fold faster than the rate of 
excision for an 8-oxodGMP/dA mismatch (mismatch data collected by David M. Thal is 
not shown).   
Incorporation of dTTP on a primer terminated with 8-oxodG 
Once incorporated into a growing strand of DNA two competing rates dictate 
whether 8-oxodG will be buried or removed.  Starting synthesis with a primer terminated 
with 8-oxodGMP (paired "correctly" with dC); we measured the kinetics of incorporation 
of the next correct nucleotide (dTTP).  Product formation as a function of time was 
plotted and fit to a single exponential in Figure 6.14A.  The single exponential rates were 
fit to a hyperbola to obtain a Kd of 9.3 ± 1.0 µM and a kpol of 1.8 ± 0.1 s-1, yielding a 
specificity constant of 0.19 ± 0.02 uM-1s-1 (Figure 6.14B).  From the rate of 
polymerization and the rate of removal we can predict that if 8-oxodGMP is incorporated 
by Pol γ, it will be buried 96 percent of the time.  Recent data by David M. Thal suggests 





















Figure 6.13:  Exonuclease removal of 8-oxodGMP 
100 nM wild-type holoenzyme was preincubated with 90 nM 26(8-oxodG)/45Cmer (the 
bold signifies bases that are directly across from one another) DNA duplex and mixed 
with Mg+2 to start the reaction.  Concentration of substrate was plotted as a function of 
time and fit to a single exponential equation to obtain a rate of excision of 0.075 ± 0.002 


































Figure 6.14:  Correct incorporation of dTTP onto a primer terminated with 8-oxodGMP 
(A) 100 nM exonuclease-deficient holoenzyme was preincubated with 90 nM 26(8-
oxodG)/45CAmer (the bold A signifies the position of incorporation) DNA duplex and 
then rapidly mixed with Mg+2 and various concentrations of dTTP (1 (○), 5 (●), 10 (□), 
30 (■), 60 ( ), and 120 ( ) µM).  Each data set was fit by non-linear regression to a 
single exponential equation to obtain the rate of incorporation.  (B) The single 
exponential rates were plotted as a function of dTTP concentration. A fit of the data to a 





DNA damage is considered of paramount importance in aging, particularly in the 
mitochondria where the majority of the ROS are produced in healthy tissues.  The levels 
of oxidative damage using 8-oxodG as a biomarker have been demonstrated to be 3- to 9-
fold higher in mtDNA than nDNA in many species and the basal levels of damage were 
inversely correlated with the maximum life spans for the species examined (108).  My 
studies show that the human mitochondrial DNA polymerase γ is capable of efficiently 
copying DNA with the oxidative lesion, 8-oxodG, present in the template. 
Two pathways are shown in the following scheme.  The left-hand pathway was 
constructed to present the experimentally determined kinetic parameters governing 
incorporation and exonuclease parameters at prior to and following 8-oxodG for the 
“correct” incorporation of dCTP across from 8-oxodG.  The right-hand pathway presents 
the kinetic parameters of each incorporation and excision event for the “incorrect” 
incorporation of dATP across from 8-oxodG.  The first step shown in the pathway 
(correct dATP incorporation) is the same for both and illustrates that there is a relatively 
small effect on the specificity constant for the incorporation of dATP just prior to 8-
oxodG when compared to the incorporation onto an undamaged DNA substrate (40 ± 7 
and 57 ± 6 µM-1s-1, respectively).  Shown along the side of each pathway is the 
probability of that particular event to occur.  For example, the "10% incorrect" beside 
dATP incorporation onto 8-oxodG represents that there is a 10% probability that dA will 
be inserted rater than the correct base dC.  The percentages for the subsequent steps in the 
pathway represent the probability that incorporation will occur rather than proofreading 
excision.  For example, there is a 98% probability that an incorrect dA:8-oxodG base pair 
will be buried by dTTP incorporation rather than the exonuclease removal of dA.  
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Furthermore, there is a 99% probability of continuing polymerization beyond dA:8-
oxodG followed by a correct dT:dA base pair by the incorporation dGTP rather than the 
exonuclease removal of the correct dT.  Thus, most mismatches opposite 8-oxodG will be 
extended and buried rather than removed by the proofreading exonuclease. 
The most hindered incorporation event is the insertion of a nucleotide directly 
across from 8-oxodG.  The specificity constant for dC incorporation across from 8-
oxodG is reduced by about 470-fold (compared to incorporation onto dG) but is 
sufficiently fast for the polymerase to continue replication.  However, the fidelity of 
replication is reduced significantly at the site of an oxidative lesion.  Discrimination 
against the formation of the undamaged mispair, dA:dG, is 280,000 ± 80000 (in press H. 
Lee and K. A. Johnson), but the discrimination is reduced to 9 ± 0.3 (over 30,000-fold) 
for the base pair dA:8-oxodG.  Pol γ discriminates relatively well against the 
incorporation of dGTP and dTTP onto 8-oxodG with discrimination values of 770 ± 240 




The processive polymerization assay starting the reaction at either the correct 
dC:8-oxodG or the incorrect dA:8-oxodG base pair in the presence of a DNA trap 
revealed that processive polymerization occurs without dissociation of the DNA from the 
enzyme active site.  The total full-length product formed in that experiment was actually 
greater when starting with the mismatch and may be due to an increase in the rate of 
dissociation of DNA from the polymerase with the correct dC:8-oxodG (Kd = 25 
compared to 38 nM).  This could be due to a distortion in the DNA duplex with the 
"correct" base pair because of the steric hindrance between the 8-oxo-group and the 
phosphate backbone, which could also contribute to the lower coding specificity of 8-
oxodG (the syn conformation is assumed when based paired with dA).   
There is growing evidence that the incorporation of 8-oxodGTP is important to 
mutagenesis, carcinogenesis and aging (75;105).  We examined the kinetics of 
incorporation for 8-oxodGTP onto both dC and dA.  Shown in the following scheme is a 
summary of the kinetic parameters obtained to date governing the incorporation of 8-
oxodGTP onto dC and dA and also shown are the kinetics of correct incorporation of 






The incorporation of 8-oxodGTP onto dC was unusual, in that the reaction 
kinetics were biphasic.  The amplitude of the fast phase of the reaction was dependent on 
concentration reminiscent of the 3′-azide analogs studied in Chapter 4.  It was proposed 
that for AZTTP incorporation, phosphoryl transfer is reversibly linked to binding, 
resulting in a concentration dependent amplitude of incorporation.  This explanation 
required that the conformational change after phosphoryl transfer was slow, trapping 
pyrophosphate in the active site, so that the reverse reaction of phosphoryl transfer 
(pyrophosphorolysis) equilibrated during incorporation.  However, I observed an 
additional slower phase of incorporation of 8-oxodGTP that was not observed with 
AZTTP incorporation.  The double exponential (8-oxodGTP incorporation), or lack 
thereof (AZTTP incorporation), may be due to the comparative difference between the 
rates of binding, phosphoryl transfer and pyrophosphate release.  Regarding AZTTP 
incorporation, the rate of pyrophosphate release was much slower than incorporation so 
that the phosphoryl transfer step reached equilibrium at the active site.  However, if 
pyrophosphate release was slightly faster, a double exponential could have been 
observed.  To explain our 8-oxodGTP incorporation data a simulation was performed to 
test this possibility.  The simulated curves with the experimentally obtained data are 
superimposed and shown in Figure 6.15. 
A good fit was obtained using the same mechanism as shown in Figure 4.18 
(AZTTP incorporation simulation) but with rates shown in the following scheme (Figure 
6.15 legend).  The conformational change following phosphoryl transfer (0.35 s-1) is 
about the same rate as the slow phase of the reaction determined experimentally (0.40 ± 
0.02 s-1).  This analysis supports a model in which the slow phase represents the rate 
limiting release of pyrophosphate allowing phosphoryl transfer to go to completion. 
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Figure 6.15:  Simulated curves for the incorporation of 8-oxodGTP onto dC 
Shown above is experimentally obtained data for the incorporation of 8-oxodGTP on to a 
template dC (dNTP in scheme) superimposed onto simulated data according to the 







Whatever the case may be for the incorporation of 8-oxodGTP onto a template 
dC, a kpol of about 2 s-1 can be estimated from the fast phase of the reaction, and an 
apparent Kd of 200 ± 30 µM can be used to estimate the specificity constant and the 
discrimination.  Discrimination against 8-oxodGTP for incorporation across from dC and 
dA is 4500 ± 1300 and 190 ± 70, respectively.  It is therefore 24-fold more likely that 8-
oxodGTP will be incorporated as a mismatch; it is a surprisingly good substrate 
compared to dTTP.  It is also unlikely that the mismatch will be repaired because the rate 
for removal of 8-oxodG across from either a dC or dA is slow in comparison to the rate 
of incorporation of the next correct nucleotide.  For example, there is a 96 percent 
probability that after 8-oxodG is inserted across from a dC it is buried by the next correct 
nucleotide rather than exonuclease removal of 8-oxodG.  Current efforts in the laboratory 
by David M. Thal are underway to measure the rate of incorporation of the next correct 
nucleotide on a primer/template with the mismatch, but preliminary data suggests that the 
mismatch will be buried with similar efficiency. 
In summary, 8-oxodG in the template DNA strand dramatically reduces the 
fidelity of incorporation (30,000-fold), coding for dA 1/10 incorporation events.  The 
polymerase is able to continue polymerization over 8-oxodG without dissociation, and 
the proofreading exonuclease activity is not effective at correcting the mismatch with dA.  
The incorporation of 8-oxodGTP appears to be especially mutagenic compared to 8-
oxodG in the template.  During the course of one's life this lack of discrimination against 
both the formation of dA:8-oxodG and 8-oxodG:dA mispairs along with the inefficient 
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